75547-0
Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA
Active
43993-5 Age at delivery
Observation Required in Panel
Required
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Age.at delivery
- Property
- Time
- Time
- Pt
- System
- ^Patient
- Scale
- Qn
- Method
Additional Names
- Short Name
- Age at delivery
Basic Attributes
- Class
- OB.US
- Type
- Clinical
- First Released
- Version 2.17
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 2477
Member of these Panels
LOINC | Long Common Name |
---|---|
58735-2 | Alpha-1-Fetoprotein panel - Amniotic fluid |
48802-3 | Alpha-1-Fetoprotein panel - Serum or Plasma |
49085-4 | First and Second trimester integrated maternal screen panel |
48798-3 | First trimester maternal screen panel - Serum or Plasma |
49086-2 | First trimester maternal screen with nuchal translucency panel |
49087-0 | Maternal screen clinical predictors panel |
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
48799-1 | Second trimester penta maternal screen panel - Serum or Plasma |
48800-7 | Second trimester quad maternal screen panel - Serum or Plasma |
35086-8 | Second trimester triple maternal screen panel - Serum or Plasma |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Edad al momento del parto: |
it-IT | Italian (Italy) | Età.al parto: Synonyms: Ecografia ostetrica Età al momento del parto paziente Punto nel tempo (episodio) Tempo (e.g. secondi) |
nl-NL | Dutch (Netherlands) | leeftijd van moeder bij geboorte: |
pt-BR | Portuguese (Brazil) | Idade.no momento do parto: Synonyms: Point in time; |
ru-RU | Russian (Russian Federation) | Возраст.в родах: Synonyms: Возраст женщины на момент родов Время (в т.ч. в секундах) Количественный Точка во времени; |
tr-TR | Turkish (Turkey) | Yaş.doğumda: |
zh-CN | Chinese (China) | 年龄.分娩时: Synonyms: 产科 产科.超声; |
Example Units
Unit | Source |
---|---|
a | Example UCUM Units |
18185-9 Gestational age
Part Descriptions
LP19507-0 Gestational age
The age of the conceptus, beginning from the time of fertilization. In clinical obstetrics, the gestational age is often estimated as the time from the last day of the last menstruation which is about 2 weeks before ovulation and fertilization.
Source: National Library of Medicine, MeSH 2006
Reference Information
Type | Source | Reference |
---|---|---|
Mapping Guidance | Regenstrief Help | This term is preferred over the two separate terms for gestational age in weeks [LOINC: 49051-6] and in days [LOINC: 49052-4] so that only one variable is used. Mapper’s Guide for the Top 2000 plus LOINC Laboratory Observations |
Observation Required in Panel
Required
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Gestational age
- Property
- Time
- Time
- Pt
- System
- ^Fetus
- Scale
- Qn
- Method
Additional Names
- Short Name
- GA
Basic Attributes
- Class
- OB.US
- Type
- Clinical
- First Released
- Version 1.0l
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 1105
Member of these Panels
LOINC | Long Common Name |
---|---|
76478-7 | Acetylcholinesterase panel - Amniotic fluid |
58735-2 | Alpha-1-Fetoprotein panel - Amniotic fluid |
48802-3 | Alpha-1-Fetoprotein panel - Serum or Plasma |
75199-0 | Congenital syphilis case investigation and report panel [CDC.CS] |
49085-4 | First and Second trimester integrated maternal screen panel |
48798-3 | First trimester maternal screen panel - Serum or Plasma |
49086-2 | First trimester maternal screen with nuchal translucency panel |
49087-0 | Maternal screen clinical predictors panel |
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
100230-2 | Routine prenatal assessment panel |
48799-1 | Second trimester penta maternal screen panel - Serum or Plasma |
48800-7 | Second trimester quad maternal screen panel - Serum or Plasma |
35086-8 | Second trimester triple maternal screen panel - Serum or Plasma |
Member of these Groups Get Info
LOINC Group | Group Name |
---|---|
LG50112-8 | Gestational ageTime^Fetus |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Edad gestacional: |
es-AR | Spanish (Argentina) | edad gestacional: |
es-ES | Spanish (Spain) | Edad gestacional: Synonyms: Cuantitativo |
et-EE | Estonian (Estonia) | Raseduse kestus: Synonyms: Juhuslik Kvantitatiivne |
fr-FR | French (France) | Âge gestationnel: |
fr-BE | French (Belgium) | Age gestationnel: |
it-IT | Italian (Italy) | Età gestazionale: Synonyms: Ecografia ostetrica Punto nel tempo (episodio) Tempo (e.g. secondi) |
nl-NL | Dutch (Netherlands) | zwangerschapsduur: |
pt-BR | Portuguese (Brazil) | Idade gestacional: Synonyms: ; |
ru-RU | Russian (Russian Federation) | Гестационный возраст: Synonyms: Время (в т.ч. в секундах) Гестационный срок Количественный Точка во времени; |
tr-TR | Turkish (Turkey) | Doğurma yaşı: Synonyms: Gestasyonel yaş |
uk-UA | Ukrainian (Ukraine) | Гестаційний вік: Synonyms: Fetal; |
zh-CN | Chinese (China) | 孕龄: Synonyms: 产科 产科.超声; |
Example Units
Unit | Source |
---|---|
wk | Example UCUM Units |
week | REGENSTRIEF |
75607-2 Paternal sample received Qualitative
Part Descriptions
LP185911-7 Paternal sample received
Paternal sample received is an indicator of whether a specimen from the father was sent to the testing laboratory. Paternal and maternal samples are relevant for prenatal fetal or postnatal testing for genetic disorders or paternity.
Source: Regenstrief LOINC
Observation Required in Panel
Required
Fully-Specified Name
- Component
- Paternal sample received
- Property
- Find
- Time
- Pt
- System
- ^Father
- Scale
- Ord
- Method
Additional Names
- Short Name
- Pat sample rec Father Ql
- Display Name
- Paternal Sample Received
- Consumer Name Alpha Get Info
- Paternal Sample Received
Basic Attributes
- Class
- MOLPATH
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
Example Answer List LL361-7
Answer | Code | Score | Answer ID |
---|---|---|---|
Yes Copyright http://snomed.info/sct ID:373066001 Yes (qualifier value) | LA33-6 | ||
No Copyright http://snomed.info/sct ID:373067005 No (qualifier value) | LA32-8 |
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Muestra paterna recibida: |
es-ES | Spanish (Spain) | Muestra paterna recibida: |
fr-FR | French (France) | Échantillon du père reçu: |
it-IT | Italian (Italy) | Campione paterno ricevuto: Synonyms: Osservazione Patologia molecolare Punto nel tempo (episodio) |
tr-TR | Turkish (Turkey) | Paternal örnek alınmış: |
zh-CN | Chinese (China) | 已收到父方样本: Synonyms: 依次型; |
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
75605-6 Cell-free DNA.fetal/Cell-free DNA.total in Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
Observation Required in Panel
Required
Fully-Specified Name
- Component
- Cell-free DNA.fetal/Cell-free DNA.total
- Property
- SFr
- Time
- Pt
- System
- Plas.cfDNA
- Scale
- Qn
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- cfDNA.fet/cfDNA.total SFr Fetus
- Display Name
- Cell-free DNA.fetal/Cell-free DNA.total Dosage of chromosome-specific cfDNA (cfDNA) [Molar fraction]
- Consumer Name Alpha Get Info
- Fetal Cell-free DNA/Total Cell-free DNA, Cell-free DNA
Basic Attributes
- Class
- MOLPATH
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 6650
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | ADN libre de células ADN fetal / libre de células total: |
es-ES | Spanish (Spain) | ADN fetal libre de células/ADN total libre de células: Synonyms: Cuantitativo |
fr-FR | French (France) | ADN libre foetal/ADN libre total: |
it-IT | Italian (Italy) | DNA libero circolante.fetale/DNA libero circolante.totale: Synonyms: DNA fetale libero circolante DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Frazione di Sostanza Patologia molecolare Plasma Punto nel tempo (episodio) |
pl-PL | Polish (Poland) | Pozakomórkowy DNA płodu/całkowita pula wolnego DNA: |
zh-CN | Chinese (China) | cfDNA.胎儿/cfDNA.总计: Synonyms: 克分子分数; |
Example Units
Unit | Source |
---|---|
% | Example UCUM Units |
75606-4 Cell-free DNA.fetal/Cell-free DNA.total in Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Narrative
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions.
Source: Regenstrief LOINC
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Cell-free DNA.fetal/Cell-free DNA.total
- Property
- Find
- Time
- Pt
- System
- Plas.cfDNA
- Scale
- Nar
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- cfDNA.fet/total Plas.cfDNA
- Display Name
- Cell-free DNA.fetal/Cell-free DNA.total Dosage of chromosome-specific cfDNA Nar (cfDNA)
- Consumer Name Alpha Get Info
- Fetal Cell-free DNA/Total Cell-free DNA, Cell-free DNA
Basic Attributes
- Class
- MOLPATH
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 10540
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | ADN libre de células ADN fetal / libre de células total: |
es-ES | Spanish (Spain) | ADN fetal libre de células/ADN total libre de células: |
fr-FR | French (France) | ADN libre foetal/ADN libre total: |
it-IT | Italian (Italy) | DNA libero circolante.fetale/DNA libero circolante.totale: Synonyms: DNA fetale libero circolante DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Osservazione Patologia molecolare Plasma Punto nel tempo (episodio) |
pl-PL | Polish (Poland) | Pozakomórkowy DNA płodu/całkowita pula wolnego DNA: |
zh-CN | Chinese (China) | cfDNA.胎儿/cfDNA.总计: Synonyms: 全体数量 全部 共计 分子病理学; |
75604-9 Fetal sex in Cell-free+Maternal WBC DNA by Dosage of chromosome specific circulating cell free (ccf) DNA
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions.
Source: Regenstrief LOINC
Condition for Inclusion
Fetal sex will be included on the report if requested by the parent(s).
Observation Required in Panel
Conditional
Fully-Specified Name
- Component
- Fetal sex
- Property
- Find
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Nom
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet sex cfDNA+DNA.Mat
- Display Name
- Sex Dosage of chromosome-specific cfDNA Nom (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Fetal Sex
Basic Attributes
- Class
- MOLPATH
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Example Answer List LL2903-4
Answer | Code | Score | Answer ID |
---|---|---|---|
Female fetus | LA21135-1 | ||
Male fetus | LA21134-4 | ||
No result | LA21136-9 |
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Sexo fetal: |
es-ES | Spanish (Spain) | Sexo fetal: |
fr-FR | French (France) | Sexe foetal: |
it-IT | Italian (Italy) | Sesso fetale: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Osservazione Patologia molecolare Plasma Punto nel tempo (episodio) |
zh-CN | Chinese (China) | 胎儿性别: Synonyms: WBC.DNA+血浆.cfDNA; |
75560-3 Fetal Trisomy 21 prior risk [Likelihood] Based on maternal age
Part Descriptions
LP185800-2 Based on maternal age
The fetal risk for having certain disorders, such as Trisomy 21, varies based on maternal age. For such disorders, an individual infant's risk can be estimated based on known population statistics for how many women in a particular age group have an infant born with the condition compared to the total number of pregnancies for that age group. For example, the fetal Trisomy 21 risk is 1 out of 1,000 for a maternal age of 30 and 1 out of 100 for a maternal age of 40.
Source: Regenstrief LOINC
Observation Required in Panel
Required
Fully-Specified Name
- Component
- Trisomy 21 prior risk
- Property
- Likelihood
- Time
- Pt
- System
- ^Fetus
- Scale
- Qn
- Method
- Based on maternal age
Additional Names
- Short Name
- Fet Ts 21 prior risk from Mat age
- Display Name
- Trisomy 21 prior risk Based on maternal age Qn (fetus)
- Consumer Name Alpha Get Info
- Fetal Trisomy 21 prior risk
Basic Attributes
- Class
- MOLPATH.TRISOMY
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo previo de trisomía 21: |
es-ES | Spanish (Spain) | Riesgo previo de Trisomía 21: Synonyms: Cuantitativo |
fr-FR | French (France) | Risque prédominant trisomie 21: |
it-IT | Italian (Italy) | Trisomia 21, rischio preesistente: Synonyms: Patologia molecolare Punto nel tempo (episodio) Rischio preesistente di trisomia 21 Trisomia cromosoma genetica |
pl-PL | Polish (Poland) | Trisomia 21 - ryzyko wstępne: |
zh-CN | Chinese (China) | 三体型 21 先验风险: Synonyms: 21 三体型综合征(唐氏综合征、 |
Example Units
Unit | Source |
---|---|
{risk} | Example UCUM Units |
75562-9 Fetal Trisomy 21 prior risk [Likelihood] Based on maternal age Narrative
Part Descriptions
LP185800-2 Based on maternal age
The fetal risk for having certain disorders, such as Trisomy 21, varies based on maternal age. For such disorders, an individual infant's risk can be estimated based on known population statistics for how many women in a particular age group have an infant born with the condition compared to the total number of pregnancies for that age group. For example, the fetal Trisomy 21 risk is 1 out of 1,000 for a maternal age of 30 and 1 out of 100 for a maternal age of 40.
Source: Regenstrief LOINC
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Trisomy 21 prior risk
- Property
- Likelihood
- Time
- Pt
- System
- ^Fetus
- Scale
- Nar
- Method
- Based on maternal age
Additional Names
- Short Name
- Fet Ts 21 prior risk from Mat age
- Display Name
- Trisomy 21 prior risk Based on maternal age Nar (fetus)
- Consumer Name Alpha Get Info
- Fetal Trisomy 21 prior risk
Basic Attributes
- Class
- MOLPATH.TRISOMY
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo previo de trisomía 21: |
es-ES | Spanish (Spain) | Riesgo previo de Trisomía 21: |
fr-FR | French (France) | Risque prédominant trisomie 21: |
it-IT | Italian (Italy) | Trisomia 21, rischio preesistente: Synonyms: Patologia molecolare Punto nel tempo (episodio) Rischio preesistente di trisomia 21 Trisomia cromosoma genetica |
pl-PL | Polish (Poland) | Trisomia 21 - ryzyko wstępne: |
zh-CN | Chinese (China) | 三体型 21 先验风险: Synonyms: 21 三体型综合征(唐氏综合征、 |
75561-1 Fetal Trisomy 21 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions. It represents the risk based on a priori risk combined with the Panorama test result.
Source: Regenstrief LOINC
Observation Required in Panel
Required
Fully-Specified Name
- Component
- Fetal trisomy 21 risk
- Property
- Likelihood
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Qn
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet Ts 21 risk WBC.DNA+cfDNA Qn
- Display Name
- Trisomy 21 risk Dosage of chromosome-specific cfDNA Qn (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Fetal Trisomy 21 risk
Basic Attributes
- Class
- MOLPATH.TRISOMY
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de trisomía 21 fetal: |
es-ES | Spanish (Spain) | Riesgo de trisomía 21 fetal: Synonyms: Cuantitativo |
fr-FR | French (France) | Risque de trisomie 21 foetale: |
it-IT | Italian (Italy) | Trisomia 21, rischio: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di trisomia 21 Trisomia cromosoma genetica |
zh-CN | Chinese (China) | 胎儿三体型 21 风险: Synonyms: 21 三体型综合征(唐氏综合征、 |
Example Units
Unit | Source |
---|---|
{risk} | Example UCUM Units |
75563-7 Fetal Trisomy 21 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions. It represents the risk based on a priori risk combined with the Panorama test result.
Source: Regenstrief LOINC
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Fetal trisomy 21 risk
- Property
- Likelihood
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Nar
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet Ts 21 risk WBC.DNA+cfDNA
- Display Name
- Trisomy 21 risk Dosage of chromosome-specific cfDNA Nar (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Fetal Trisomy 21 risk
Basic Attributes
- Class
- MOLPATH.TRISOMY
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de trisomía 21 fetal: |
es-ES | Spanish (Spain) | Riesgo de trisomía 21 fetal: |
fr-FR | French (France) | Risque de trisomie 21 foetale: |
it-IT | Italian (Italy) | Trisomia 21, rischio: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di trisomia 21 Trisomia cromosoma genetica |
zh-CN | Chinese (China) | 胎儿三体型 21 风险: Synonyms: 21 三体型综合征(唐氏综合征、 |
75564-5 Fetal Trisomy 21 risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions.
Source: Regenstrief LOINC
Observation Required in Panel
Required
Fully-Specified Name
- Component
- Fetal trisomy 21 risk
- Property
- Imp
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Ord
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet Ts 21 risk WBC.DNA+cfDNA Ql
- Display Name
- Trisomy 21 risk Dosage of chromosome-specific cfDNA Ql (Plasma cell-free+WBC DNA) [Interp]
- Consumer Name Alpha Get Info
- Fetal Trisomy 21 risk
Basic Attributes
- Class
- MOLPATH.TRISOMY
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Example Answer List LL3000-8
Answer | Code | Score | Answer ID |
---|---|---|---|
Low risk | LA19542-2 | ||
High risk | LA19541-4 | ||
Risk unchanged | LA21393-6 | ||
Test not performed Copyright http://snomed.info/sct ID:262008008 Not performed (qualifier value) | LA13546-9 |
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de trisomía 21 fetal: |
es-ES | Spanish (Spain) | Riesgo de trisomía 21 fetal: |
fr-FR | French (France) | Risque de trisomie 21 foetale: |
it-IT | Italian (Italy) | Trisomia 21, rischio: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Impressione/interpretazione di studio Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di trisomia 21 Trisomia cromosoma genetica |
zh-CN | Chinese (China) | 胎儿三体型 21 风险: Synonyms: 21 三体型综合征(唐氏综合征、 |
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
75565-2 Comment on fetal Trisomy 21 risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions.
Source: Regenstrief LOINC
Part Descriptions
LP185987-7 Comment on fetal Trisomy 21 risk
Trisomy 21 risk refers to the fetus's risk of having trisomy 21. The risk can be estimated based on maternal age, prenatal genetic testing of fetal DNA, various maternal lab tests, and fetal nuchal translucency or nuchal fold measurements. Trisomy 21, also called Down syndrome, is caused by the presence of three copies of either the entire chromosome 21 or a crucial region of chromosome 21 in each cell rather than two. Down syndrome is associated with cognitive delay, various forms of congenital heart disease, hearing loss, and leukemia, and characteristic physical features. The risk for Down syndrome increases with increasing maternal age. The general population risk of Down syndrome is 1 out of 650 to 1,000 live births; for a 30-year-old woman, the risk is 1 out of 1,000, while for a 40-year-old woman it nears 1 out of 100. [OMIM: 190685]
Source: Regenstrief LOINC, OMIM: 190685
LP185987-7 Comment on fetal Trisomy 21 risk
The genetic counselor's comment regarding risk of a specific disorder or group of disorders is used to convey follow-up recommendations or other information related to the risk result and interpretation.
Source: Regenstrief LOINC
Condition for Inclusion
If fetal trisomy 21 risk is high, a genetic counselor comment should be included.
Observation Required in Panel
Conditional
Fully-Specified Name
- Component
- Comment on fetal Trisomy 21 risk
- Property
- Txt
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Nar
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet Ts 21 risk comment
- Display Name
- Comment on Trisomy 21 risk Dosage of chromosome-specific cfDNA Nar (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Fetal Comment on trisomy 21 risk
Basic Attributes
- Class
- MOLPATH.TRISOMY
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Release 2.70: COMPONENT: Removed "Genetic counselor" to broaden use since various specialists may provide comments on test results.; Previous Releases: Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Comentario del asesor genético sobre el riesgo de trisomía 21 fetal: |
es-ES | Spanish (Spain) | Comentario de consejo genético en riesgo de Trisomía 21: |
fr-FR | French (France) | Risque trisomie 21 foetale (commentaire du conseiller génétique): |
it-IT | Italian (Italy) | Commento su rischio Trisomia 21: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di trisomia 21 Testo Trisomia cromosoma genetica |
pl-PL | Polish (Poland) | Komentarz dotyczący ryzyka trisomii 21 u płodu: |
zh-CN | Chinese (China) | 关于胎儿三体型 21 风险的遗传咨询师意见: Synonyms: 21 三体型综合征(唐氏综合征、 |
75554-6 Fetal Trisomy 18 prior risk [Likelihood] Based on maternal age
Part Descriptions
LP185800-2 Based on maternal age
The fetal risk for having certain disorders, such as Trisomy 21, varies based on maternal age. For such disorders, an individual infant's risk can be estimated based on known population statistics for how many women in a particular age group have an infant born with the condition compared to the total number of pregnancies for that age group. For example, the fetal Trisomy 21 risk is 1 out of 1,000 for a maternal age of 30 and 1 out of 100 for a maternal age of 40.
Source: Regenstrief LOINC
Observation Required in Panel
Required
Fully-Specified Name
- Component
- Trisomy 18 prior risk
- Property
- Likelihood
- Time
- Pt
- System
- ^Fetus
- Scale
- Qn
- Method
- Based on maternal age
Additional Names
- Short Name
- Fet Ts 18 prior risk from Mat age
- Display Name
- Trisomy 18 prior risk Based on maternal age Qn (fetus)
- Consumer Name Alpha Get Info
- Fetal Trisomy 18 prior risk
Basic Attributes
- Class
- MOLPATH.TRISOMY
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Trisomía 18 riesgo previo: |
es-ES | Spanish (Spain) | Riesgo previo de Trisomía 18: Synonyms: Cuantitativo |
fr-FR | French (France) | Risque prédominant trisomie 18: |
it-IT | Italian (Italy) | Trisomia 18, rischio preesistente: Synonyms: Patologia molecolare Punto nel tempo (episodio) Rischio preesistente di trisomia 13 Trisomia cromosoma genetica |
pl-PL | Polish (Poland) | Trisomia 18 - ryzyko wstępne: |
zh-CN | Chinese (China) | 三体型 18 先验风险: Synonyms: 三体型 三体型 18 先验风险(事前风险、 |
Example Units
Unit | Source |
---|---|
{risk} | Example UCUM Units |
75556-1 Fetal Trisomy 18 prior risk [Likelihood] Based on maternal age Narrative
Part Descriptions
LP185800-2 Based on maternal age
The fetal risk for having certain disorders, such as Trisomy 21, varies based on maternal age. For such disorders, an individual infant's risk can be estimated based on known population statistics for how many women in a particular age group have an infant born with the condition compared to the total number of pregnancies for that age group. For example, the fetal Trisomy 21 risk is 1 out of 1,000 for a maternal age of 30 and 1 out of 100 for a maternal age of 40.
Source: Regenstrief LOINC
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Trisomy 18 prior risk
- Property
- Likelihood
- Time
- Pt
- System
- ^Fetus
- Scale
- Nar
- Method
- Based on maternal age
Additional Names
- Short Name
- Fet Ts 18 prior risk from Mat age
- Display Name
- Trisomy 18 prior risk Based on maternal age Nar (fetus)
- Consumer Name Alpha Get Info
- Fetal Trisomy 18 prior risk
Basic Attributes
- Class
- MOLPATH.TRISOMY
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Trisomía 18 riesgo previo: |
es-ES | Spanish (Spain) | Riesgo previo de Trisomía 18: |
fr-FR | French (France) | Risque prédominant trisomie 18: |
it-IT | Italian (Italy) | Trisomia 18, rischio preesistente: Synonyms: Patologia molecolare Punto nel tempo (episodio) Rischio preesistente di trisomia 13 Trisomia cromosoma genetica |
pl-PL | Polish (Poland) | Trisomia 18 - ryzyko wstępne: |
zh-CN | Chinese (China) | 三体型 18 先验风险: Synonyms: 三体型 三体型 18 先验风险(事前风险、 |
75555-3 Fetal Trisomy 18 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions. It represents the risk based on a priori risk combined with the Panorama test result.
Source: Regenstrief LOINC
Observation Required in Panel
Required
Fully-Specified Name
- Component
- Fetal trisomy 18 risk
- Property
- Likelihood
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Qn
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet Ts 18 risk WBC.DNA+cfDNA Qn
- Display Name
- Trisomy 18 risk Dosage of chromosome-specific cfDNA Qn (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Fetal Trisomy 18 risk
Basic Attributes
- Class
- MOLPATH.TRISOMY
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de trisomía 18 fetal: |
es-ES | Spanish (Spain) | Riesgo de trisomía 18 fetal: Synonyms: Cuantitativo |
fr-FR | French (France) | Risque de trisomie 18 foetale: |
it-IT | Italian (Italy) | Trisomia 18, rischio: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di trisomia 18 Trisomia cromosoma genetica |
zh-CN | Chinese (China) | 胎儿三体型 18 风险: Synonyms: 18 三体型综合征风险(危险性、 |
Example Units
Unit | Source |
---|---|
{risk} | Example UCUM Units |
75557-9 Fetal Trisomy 18 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions. It represents the risk based on a priori risk combined with the Panorama test result.
Source: Regenstrief LOINC
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Fetal trisomy 18 risk
- Property
- Likelihood
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Nar
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet Ts 18 risk WBC.DNA+cfDNA
- Display Name
- Trisomy 18 risk Dosage of chromosome-specific cfDNA Nar (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Fetal Trisomy 18 risk
Basic Attributes
- Class
- MOLPATH.TRISOMY
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de trisomía 18 fetal: |
es-ES | Spanish (Spain) | Riesgo de trisomía 18 fetal: |
fr-FR | French (France) | Risque de trisomie 18 foetale: |
it-IT | Italian (Italy) | Trisomia 18, rischio: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di trisomia 18 Trisomia cromosoma genetica |
zh-CN | Chinese (China) | 胎儿三体型 18 风险: Synonyms: 18 三体型综合征风险(危险性、 |
75558-7 Fetal Trisomy 18 risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions.
Source: Regenstrief LOINC
Observation Required in Panel
Required
Fully-Specified Name
- Component
- Fetal trisomy 18 risk
- Property
- Imp
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Ord
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet Ts 18 risk WBC.DNA+cfDNA Ql
- Display Name
- Trisomy 18 risk Dosage of chromosome-specific cfDNA Ql (Plasma cell-free+WBC DNA) [Interp]
- Consumer Name Alpha Get Info
- Fetal Trisomy 18 risk
Basic Attributes
- Class
- MOLPATH.TRISOMY
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Example Answer List LL3000-8
Answer | Code | Score | Answer ID |
---|---|---|---|
Low risk | LA19542-2 | ||
High risk | LA19541-4 | ||
Risk unchanged | LA21393-6 | ||
Test not performed Copyright http://snomed.info/sct ID:262008008 Not performed (qualifier value) | LA13546-9 |
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de trisomía 18 fetal: |
es-ES | Spanish (Spain) | Riesgo de trisomía 18 fetal: |
fr-FR | French (France) | Risque de trisomie 18 foetale: |
it-IT | Italian (Italy) | Trisomia 18, rischio: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Impressione/interpretazione di studio Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di trisomia 18 Trisomia cromosoma genetica |
zh-CN | Chinese (China) | 胎儿三体型 18 风险: Synonyms: 18 三体型综合征风险(危险性、 |
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
75559-5 Comment on fetal Trisomy 18 risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions.
Source: Regenstrief LOINC
Part Descriptions
LP185986-9 Comment on fetal Trisomy 18 risk
Trisomy 18 risk refers to the fetus's risk of having trisomy 18. The risk can be estimated based on maternal age and prenatal genetic testing of fetal DNA.Trisomy 18, also called Edwards syndrome, is caused by the presence of three copies of chromosome 18 in each cell rather than two. Edwards syndrome is associated with intrauterine growth retardation and fetal demise, and liveborn infants with Edwards syndrome typically have low birth weight, congenital heart disease, and characteristic physical features. Less than 10% of liveborn infants with Edwards syndrome live past their first year. The general population risk of Edwards syndrome is 1 out of 5,000 live births, and the risk for Edwards syndrome increases with increasing maternal age. [MedlinePlus Condition: trisomy-18]
Source: Regenstrief LOINC, GHR: Trisomy 18
LP185986-9 Comment on fetal Trisomy 18 risk
The genetic counselor's comment regarding risk of a specific disorder or group of disorders is used to convey follow-up recommendations or other information related to the risk result and interpretation.
Source: Regenstrief LOINC
Condition for Inclusion
If fetal trisomy 18 risk is high, a genetic counselor comment should be included.
Observation Required in Panel
Conditional
Fully-Specified Name
- Component
- Comment on fetal Trisomy 18 risk
- Property
- Txt
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Nar
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet Ts 18 risk comment
- Display Name
- Comment on Trisomy 18 risk Dosage of chromosome-specific cfDNA Nar (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Fetal Comment on trisomy 18 risk
Basic Attributes
- Class
- MOLPATH.TRISOMY
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Release 2.70: COMPONENT: Removed "Genetic counselor" to broaden use since various specialists may provide comments on test results.; Previous Releases: Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Comentario del consejero genético sobre el riesgo de trisomía 18 fetal: |
es-ES | Spanish (Spain) | Comentario de consejo genético en riesgo de Trisomía 18: |
fr-FR | French (France) | Risque trisomie 18 foetale (commentaire du conseiller génétique): |
it-IT | Italian (Italy) | Commento su rischio Trisomia 18: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di trisomia 18 Testo Trisomia cromosoma genetica |
pl-PL | Polish (Poland) | Komentarz dotyczący ryzyka trisomii 18 u płodu: |
zh-CN | Chinese (China) | 关于胎儿三体型 18 风险的遗传咨询师意见: Synonyms: 18 三体型综合征风险(危险性、 |
75546-2 Fetal Trisomy 13 prior risk [Likelihood] Based on maternal age
Part Descriptions
LP185800-2 Based on maternal age
The fetal risk for having certain disorders, such as Trisomy 21, varies based on maternal age. For such disorders, an individual infant's risk can be estimated based on known population statistics for how many women in a particular age group have an infant born with the condition compared to the total number of pregnancies for that age group. For example, the fetal Trisomy 21 risk is 1 out of 1,000 for a maternal age of 30 and 1 out of 100 for a maternal age of 40.
Source: Regenstrief LOINC
Observation Required in Panel
Required
Fully-Specified Name
- Component
- Trisomy 13 prior risk
- Property
- Likelihood
- Time
- Pt
- System
- ^Fetus
- Scale
- Qn
- Method
- Based on maternal age
Additional Names
- Short Name
- Fet Ts 13 prior risk from Mat age
- Display Name
- Trisomy 13 prior risk Based on maternal age Qn (fetus)
- Consumer Name Alpha Get Info
- Fetal Trisomy 13 prior risk
Basic Attributes
- Class
- MOLPATH.TRISOMY
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 8172
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Trisomía 13 riesgo previo: |
es-ES | Spanish (Spain) | Riesgo previo de trisomía 13: Synonyms: Cuantitativo |
fr-FR | French (France) | Risque prédominant trisomie 13: |
it-IT | Italian (Italy) | Trisomia 13, rischio preesistente: Synonyms: Patologia molecolare Punto nel tempo (episodio) Rischio preesistente di trisomia 13 Trisomia cromosoma genetica |
zh-CN | Chinese (China) | 三体型 13 先验风险: Synonyms: 三体型 三体型 13 先验风险(事前风险、 |
Example Units
Unit | Source |
---|---|
{risk} | Example UCUM Units |
75550-4 Fetal Trisomy 13 prior risk [Likelihood] Based on maternal age Narrative
Part Descriptions
LP185800-2 Based on maternal age
The fetal risk for having certain disorders, such as Trisomy 21, varies based on maternal age. For such disorders, an individual infant's risk can be estimated based on known population statistics for how many women in a particular age group have an infant born with the condition compared to the total number of pregnancies for that age group. For example, the fetal Trisomy 21 risk is 1 out of 1,000 for a maternal age of 30 and 1 out of 100 for a maternal age of 40.
Source: Regenstrief LOINC
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Trisomy 13 prior risk
- Property
- Likelihood
- Time
- Pt
- System
- ^Fetus
- Scale
- Nar
- Method
- Based on maternal age
Additional Names
- Short Name
- Fet Ts 13 prior risk from Mat age
- Display Name
- Trisomy 13 prior risk Based on maternal age Nar (fetus)
- Consumer Name Alpha Get Info
- Fetal Trisomy 13 prior risk
Basic Attributes
- Class
- MOLPATH.TRISOMY
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Trisomía 13 riesgo previo: |
es-ES | Spanish (Spain) | Riesgo previo de trisomía 13: |
fr-FR | French (France) | Risque prédominant trisomie 13: |
it-IT | Italian (Italy) | Trisomia 13, rischio preesistente: Synonyms: Patologia molecolare Punto nel tempo (episodio) Rischio preesistente di trisomia 13 Trisomia cromosoma genetica |
zh-CN | Chinese (China) | 三体型 13 先验风险: Synonyms: 三体型 三体型 13 先验风险(事前风险、 |
75548-8 Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions. It represents the risk based on a priori risk combined with the Panorama test result.
Source: Regenstrief LOINC
Part Descriptions
LP99499-3 Fetal trisomy 13 risk
Trisomy 13 risk refers to the fetus's risk of having trisomy 13. The risk can be estimated based on maternal age as well as prenatal genetic testing of fetal DNA. Trisomy 13, also called Patau syndrome, is caused by the presence of three copies of chromosome 13 in each cell rather than two. Patau syndrome is associated with severe cognitive delay, various forms of congenital heart disease, brain or spinal cord abnormalities, hypotonia, cleft lip and/or palate, and poorly developed eyes. Many liveborn infants with Patau syndrome die within the first weeks of life, and less than 10% survive longer than one year. The general population risk of Trisomy 13 is about 1 in 16,000 live births, but the risk increases with increasing maternal age. [MedlinePlus Condition: trisomy-13]
Source: Regenstrief LOINC, GHR: Trisomy 13
Observation Required in Panel
Required
Fully-Specified Name
- Component
- Fetal trisomy 13 risk
- Property
- Likelihood
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Qn
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet Ts 13 risk WBC.DNA+cfDNA Qn
- Display Name
- Trisomy 13 risk Dosage of chromosome-specific cfDNA Qn (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Fetal Trisomy 13 risk
Basic Attributes
- Class
- MOLPATH.TRISOMY
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de trisomía 13 fetal: |
es-ES | Spanish (Spain) | Riesgo de trisomía 13: Synonyms: Cuantitativo |
fr-FR | French (France) | Risque de trisomie 13 foetale: |
it-IT | Italian (Italy) | Trisomia 13, rischio: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di trisomia 13 Trisomia cromosoma genetica |
zh-CN | Chinese (China) | 胎儿三体型 13 风险: Synonyms: WBC.DNA+血浆.cfDNA; |
Example Units
Unit | Source |
---|---|
{risk} | Example UCUM Units |
75551-2 Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions. It represents the risk based on a priori risk combined with the Panorama test result.
Source: Regenstrief LOINC
Part Descriptions
LP99499-3 Fetal trisomy 13 risk
Trisomy 13 risk refers to the fetus's risk of having trisomy 13. The risk can be estimated based on maternal age as well as prenatal genetic testing of fetal DNA. Trisomy 13, also called Patau syndrome, is caused by the presence of three copies of chromosome 13 in each cell rather than two. Patau syndrome is associated with severe cognitive delay, various forms of congenital heart disease, brain or spinal cord abnormalities, hypotonia, cleft lip and/or palate, and poorly developed eyes. Many liveborn infants with Patau syndrome die within the first weeks of life, and less than 10% survive longer than one year. The general population risk of Trisomy 13 is about 1 in 16,000 live births, but the risk increases with increasing maternal age. [MedlinePlus Condition: trisomy-13]
Source: Regenstrief LOINC, GHR: Trisomy 13
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Fetal trisomy 13 risk
- Property
- Likelihood
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Nar
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet Ts 13 risk WBC.DNA+cfDNA
- Display Name
- Trisomy 13 risk Dosage of chromosome-specific cfDNA Nar (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Fetal Trisomy 13 risk
Basic Attributes
- Class
- MOLPATH.TRISOMY
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de trisomía 13 fetal: |
es-ES | Spanish (Spain) | Riesgo de trisomía 13: |
fr-FR | French (France) | Risque de trisomie 13 foetale: |
it-IT | Italian (Italy) | Trisomia 13, rischio: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di trisomia 13 Trisomia cromosoma genetica |
zh-CN | Chinese (China) | 胎儿三体型 13 风险: Synonyms: WBC.DNA+血浆.cfDNA; |
75552-0 Fetal Trisomy 13 risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions.
Source: Regenstrief LOINC
Part Descriptions
LP99499-3 Fetal trisomy 13 risk
Trisomy 13 risk refers to the fetus's risk of having trisomy 13. The risk can be estimated based on maternal age as well as prenatal genetic testing of fetal DNA. Trisomy 13, also called Patau syndrome, is caused by the presence of three copies of chromosome 13 in each cell rather than two. Patau syndrome is associated with severe cognitive delay, various forms of congenital heart disease, brain or spinal cord abnormalities, hypotonia, cleft lip and/or palate, and poorly developed eyes. Many liveborn infants with Patau syndrome die within the first weeks of life, and less than 10% survive longer than one year. The general population risk of Trisomy 13 is about 1 in 16,000 live births, but the risk increases with increasing maternal age. [MedlinePlus Condition: trisomy-13]
Source: Regenstrief LOINC, GHR: Trisomy 13
Observation Required in Panel
Required
Fully-Specified Name
- Component
- Fetal trisomy 13 risk
- Property
- Imp
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Ord
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet Ts 13 risk WBC.DNA+cfDNA Ql
- Display Name
- Trisomy 13 risk Dosage of chromosome-specific cfDNA Ql (Plasma cell-free+WBC DNA) [Interp]
- Consumer Name Alpha Get Info
- Fetal Trisomy 13 risk
Basic Attributes
- Class
- MOLPATH.TRISOMY
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Example Answer List LL3000-8
Answer | Code | Score | Answer ID |
---|---|---|---|
Low risk | LA19542-2 | ||
High risk | LA19541-4 | ||
Risk unchanged | LA21393-6 | ||
Test not performed Copyright http://snomed.info/sct ID:262008008 Not performed (qualifier value) | LA13546-9 |
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de trisomía 13 fetal: |
es-ES | Spanish (Spain) | Riesgo de trisomía 13: |
fr-FR | French (France) | Risque de trisomie 13 foetale: |
it-IT | Italian (Italy) | Trisomia 13, rischio: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Impressione/interpretazione di studio Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di trisomia 13 Trisomia cromosoma genetica |
zh-CN | Chinese (China) | 胎儿三体型 13 风险: Synonyms: WBC.DNA+血浆.cfDNA; |
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
75553-8 Comment on fetal Trisomy 13 risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions.
Source: Regenstrief LOINC
Part Descriptions
LP185802-8 Comment on fetal Trisomy 13 risk
Trisomy 13 risk refers to the fetus's risk of having trisomy 13. The risk can be estimated based on maternal age as well as prenatal genetic testing of fetal DNA. Trisomy 13, also called Patau syndrome, is caused by the presence of three copies of chromosome 13 in each cell rather than two. Patau syndrome is associated with severe cognitive delay, various forms of congenital heart disease, brain or spinal cord abnormalities, hypotonia, cleft lip and/or palate, and poorly developed eyes. Many liveborn infants with Patau syndrome die within the first weeks of life, and less than 10% survive longer than one year. The general population risk of Trisomy 13 is about 1 in 16,000 live births, but the risk increases with increasing maternal age. [MedlinePlus Condition: trisomy-13]
Source: Regenstrief LOINC, GHR: Trisomy 13
LP185802-8 Comment on fetal Trisomy 13 risk
The genetic counselor's comment regarding risk of a specific disorder or group of disorders is used to convey follow-up recommendations or other information related to the risk result and interpretation.
Source: Regenstrief LOINC
Condition for Inclusion
If fetal trisomy 13 risk is high, a genetic counselor comment should be included.
Observation Required in Panel
Conditional
Fully-Specified Name
- Component
- Comment on fetal Trisomy 13 risk
- Property
- Txt
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Nar
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet Ts 13 risk comment
- Display Name
- Comment on Trisomy 13 risk Dosage of chromosome-specific cfDNA Nar (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Fetal Comment on trisomy 13 risk
Basic Attributes
- Class
- MOLPATH.TRISOMY
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Release 2.70: COMPONENT: Removed "Genetic counselor" to broaden use since various specialists may provide comments on test results.; Previous Releases: Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Comentario del asesor genético sobre el riesgo de trisomía 13 fetal: |
es-ES | Spanish (Spain) | Comentario de consejo genético en riesgo de Trisomía 13: |
fr-FR | French (France) | Risque trisomie 13 foetale (commentaire du conseiller génétique): |
it-IT | Italian (Italy) | Commento su rischio Trisomia 13: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di trisomia 13 Testo Trisomia cromosoma genetica |
zh-CN | Chinese (China) | 关于胎儿三体型 13 风险的遗传咨询师意见: Synonyms: WBC.DNA+血浆.cfDNA; |
75566-0 Fetal Monosomy X prior risk [Likelihood] Based on maternal age
Part Descriptions
LP185800-2 Based on maternal age
The fetal risk for having certain disorders, such as Trisomy 21, varies based on maternal age. For such disorders, an individual infant's risk can be estimated based on known population statistics for how many women in a particular age group have an infant born with the condition compared to the total number of pregnancies for that age group. For example, the fetal Trisomy 21 risk is 1 out of 1,000 for a maternal age of 30 and 1 out of 100 for a maternal age of 40.
Source: Regenstrief LOINC
Observation Required in Panel
Required
Fully-Specified Name
- Component
- Monosomy X prior risk
- Property
- Likelihood
- Time
- Pt
- System
- ^Fetus
- Scale
- Qn
- Method
- Based on maternal age
Additional Names
- Short Name
- Fet Ms X prior risk from Mat age
- Display Name
- Monosomy X prior risk Based on maternal age Qn (fetus)
- Consumer Name Alpha Get Info
- Fetal Monosomy X Prior Risk
Basic Attributes
- Class
- MOLPATH
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo previo de la monosomía X: |
es-ES | Spanish (Spain) | Riesgo previo de monosomía X: Synonyms: Cuantitativo |
fr-FR | French (France) | Risque prédominant monosomie X: |
it-IT | Italian (Italy) | Monosomia X, rischio preesistente: Synonyms: Patologia molecolare Punto nel tempo (episodio) Rischio preesistente di monosomia X |
zh-CN | Chinese (China) | 单体型 X 先验风险: Synonyms: 分子病理学; |
Example Units
Unit | Source |
---|---|
{risk} | Example UCUM Units |
75568-6 Fetal Monosomy X prior risk [Likelihood] Based on maternal age Narrative
Part Descriptions
LP185800-2 Based on maternal age
The fetal risk for having certain disorders, such as Trisomy 21, varies based on maternal age. For such disorders, an individual infant's risk can be estimated based on known population statistics for how many women in a particular age group have an infant born with the condition compared to the total number of pregnancies for that age group. For example, the fetal Trisomy 21 risk is 1 out of 1,000 for a maternal age of 30 and 1 out of 100 for a maternal age of 40.
Source: Regenstrief LOINC
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Monosomy X prior risk
- Property
- Likelihood
- Time
- Pt
- System
- ^Fetus
- Scale
- Nar
- Method
- Based on maternal age
Additional Names
- Short Name
- Fet Ms X prior risk from Mat age
- Display Name
- Monosomy X prior risk Based on maternal age Nar (fetus)
- Consumer Name Alpha Get Info
- Fetal Monosomy X Prior Risk
Basic Attributes
- Class
- MOLPATH
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo previo de la monosomía X: |
es-ES | Spanish (Spain) | Riesgo previo de monosomía X: |
fr-FR | French (France) | Risque prédominant monosomie X: |
it-IT | Italian (Italy) | Monosomia X, rischio preesistente: Synonyms: Patologia molecolare Punto nel tempo (episodio) Rischio preesistente di monosomia X |
zh-CN | Chinese (China) | 单体型 X 先验风险: Synonyms: 分子病理学; |
75567-8 Fetal Monosomy X risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions. It represents the risk based on a priori risk combined with the Panorama test result.
Source: Regenstrief LOINC
Part Descriptions
LP185775-6 Fetal monosomy X risk
Monosomy X risk refers to the fetus's risk of having monosomy X, also known as Turner syndrome. The risk can be estimated based on gestational age as well as prenatal genetic testing of fetal DNA.Monosomy X is caused by the presence of a single normal copy of chromosome X in each cell rather than 2 normal copies of X or one X and one Y chromosome. In many cases, critical portions of the second X chromosome may be missing rather than the entire chromosome. Turner syndrome is associated with ovarian dysfunction, short stature and other characteristic physical features, and up to half of girls with Turner syndrome have congenital heart disease. Turner syndrome is not associated with cognitive delay. The general population risk of monosomy X is about 1 in 2,500 live female births, and does not change with maternal age. [MedlinePlus Condition: turner-syndrome]
Source: Regenstrief LOINC, GHR: Turner syndrome
Observation Required in Panel
Required
Fully-Specified Name
- Component
- Fetal monosomy X risk
- Property
- Likelihood
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Qn
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet Ms X risk WBC.DNA+cfDNA Qn
- Display Name
- Monosomy X risk Dosage of chromosome-specific cfDNA Qn (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Fetal Monosomy X Risk
Basic Attributes
- Class
- MOLPATH
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de monosomía X fetal: |
es-ES | Spanish (Spain) | Riesgo de monosomía X: Synonyms: Cuantitativo |
fr-FR | French (France) | Risque de monosomie X foetale: |
it-IT | Italian (Italy) | Monosomia X, rischio: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di monosomia X |
zh-CN | Chinese (China) | 胎儿单体型 X 风险: Synonyms: WBC.DNA+血浆.cfDNA; |
Example Units
Unit | Source |
---|---|
{risk} | Example UCUM Units |
75569-4 Fetal Monosomy X risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions. It represents the risk based on a priori risk combined with the Panorama test result.
Source: Regenstrief LOINC
Part Descriptions
LP185775-6 Fetal monosomy X risk
Monosomy X risk refers to the fetus's risk of having monosomy X, also known as Turner syndrome. The risk can be estimated based on gestational age as well as prenatal genetic testing of fetal DNA.Monosomy X is caused by the presence of a single normal copy of chromosome X in each cell rather than 2 normal copies of X or one X and one Y chromosome. In many cases, critical portions of the second X chromosome may be missing rather than the entire chromosome. Turner syndrome is associated with ovarian dysfunction, short stature and other characteristic physical features, and up to half of girls with Turner syndrome have congenital heart disease. Turner syndrome is not associated with cognitive delay. The general population risk of monosomy X is about 1 in 2,500 live female births, and does not change with maternal age. [MedlinePlus Condition: turner-syndrome]
Source: Regenstrief LOINC, GHR: Turner syndrome
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Fetal monosomy X risk
- Property
- Likelihood
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Nar
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet Ms X risk WBC.DNA+cfDNA
- Display Name
- Monosomy X risk Dosage of chromosome-specific cfDNA Nar (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Fetal Monosomy X Risk
Basic Attributes
- Class
- MOLPATH
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de monosomía X fetal: |
es-ES | Spanish (Spain) | Riesgo de monosomía X: |
fr-FR | French (France) | Risque de monosomie X foetale: |
it-IT | Italian (Italy) | Monosomia X, rischio: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di monosomia X |
zh-CN | Chinese (China) | 胎儿单体型 X 风险: Synonyms: WBC.DNA+血浆.cfDNA; |
75570-2 Fetal Monosomy X risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions.
Source: Regenstrief LOINC
Part Descriptions
LP185775-6 Fetal monosomy X risk
Monosomy X risk refers to the fetus's risk of having monosomy X, also known as Turner syndrome. The risk can be estimated based on gestational age as well as prenatal genetic testing of fetal DNA.Monosomy X is caused by the presence of a single normal copy of chromosome X in each cell rather than 2 normal copies of X or one X and one Y chromosome. In many cases, critical portions of the second X chromosome may be missing rather than the entire chromosome. Turner syndrome is associated with ovarian dysfunction, short stature and other characteristic physical features, and up to half of girls with Turner syndrome have congenital heart disease. Turner syndrome is not associated with cognitive delay. The general population risk of monosomy X is about 1 in 2,500 live female births, and does not change with maternal age. [MedlinePlus Condition: turner-syndrome]
Source: Regenstrief LOINC, GHR: Turner syndrome
Observation Required in Panel
Required
Fully-Specified Name
- Component
- Fetal monosomy X risk
- Property
- Imp
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Ord
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet Ms X risk WBC.DNA+cfDNA Ql
- Display Name
- Monosomy X risk Dosage of chromosome-specific cfDNA Ql (Plasma cell-free+WBC DNA) [Interp]
- Consumer Name Alpha Get Info
- Fetal Monosomy X Risk
Basic Attributes
- Class
- MOLPATH
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Example Answer List LL3000-8
Answer | Code | Score | Answer ID |
---|---|---|---|
Low risk | LA19542-2 | ||
High risk | LA19541-4 | ||
Risk unchanged | LA21393-6 | ||
Test not performed Copyright http://snomed.info/sct ID:262008008 Not performed (qualifier value) | LA13546-9 |
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de monosomía X fetal: |
es-ES | Spanish (Spain) | Riesgo de monosomía X: |
fr-FR | French (France) | Risque de monosomie X foetale: |
it-IT | Italian (Italy) | Monosomia X, rischio: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Impressione/interpretazione di studio Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di monosomia X |
zh-CN | Chinese (China) | 胎儿单体型 X 风险: Synonyms: WBC.DNA+血浆.cfDNA; |
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
75571-0 Comment on fetal Monosomy X risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions.
Source: Regenstrief LOINC
Part Descriptions
LP185988-5 Comment on fetal Monosomy X risk
Monosomy X risk refers to the fetus's risk of having monosomy X, also known as Turner syndrome. The risk can be estimated based on gestational age as well as prenatal genetic testing of fetal DNA.Monosomy X is caused by the presence of a single normal copy of chromosome X in each cell rather than 2 normal copies of X or one X and one Y chromosome. In many cases, critical portions of the second X chromosome may be missing rather than the entire chromosome. Turner syndrome is associated with ovarian dysfunction, short stature and other characteristic physical features, and up to half of girls with Turner syndrome have congenital heart disease. Turner syndrome is not associated with cognitive delay. The general population risk of monosomy X is about 1 in 2,500 live female births, and does not change with maternal age. [MedlinePlus Condition: turner-syndrome]
Source: Regenstrief LOINC, GHR: Turner syndrome
LP185988-5 Comment on fetal Monosomy X risk
The genetic counselor's comment regarding risk of a specific disorder or group of disorders is used to convey follow-up recommendations or other information related to the risk result and interpretation.
Source: Regenstrief LOINC
Condition for Inclusion
If fetal Monosomy X risk is high, a genetic counselor comment should be included.
Observation Required in Panel
Conditional
Fully-Specified Name
- Component
- Comment on fetal Monosomy X risk
- Property
- Txt
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Nar
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet Mon X 13 risk comment
- Display Name
- Comment on Monosomy X risk Dosage of chromosome-specific cfDNA Nar (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Comment on Monosomy X Risk
Basic Attributes
- Class
- MOLPATH
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Release 2.70: COMPONENT: Removed "Genetic counselor" to broaden use since various specialists may provide comments on test results.; Previous Releases: Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Comentario de consejo genético en riesgo de Monosomía X: |
es-MX | Spanish (Mexico) | Comentario del asesor genético sobre el riesgo de monosomía X fetal: |
fr-FR | French (France) | Risque monosomie X foetale (commentaire du conseiller génétique): |
it-IT | Italian (Italy) | Commento su rischio Monosomia X: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di monosomia X Testo |
pl-PL | Polish (Poland) | Komentarz dotyczący ryzyka monosomii X u płodu: |
zh-CN | Chinese (China) | 关于胎儿单体型 X 风险的遗传咨询师意见: Synonyms: WBC.DNA+血浆.cfDNA; |
75572-8 Fetal Triploidy risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions.
Source: Regenstrief LOINC
Part Descriptions
LP185909-1 Fetal triploidy risk
Triploidy risk refers to the fetus's risk of being affected by triploid syndrome. The risk can be determined by prenatal genetic testing of fetal DNA. Triploid syndrome is caused by the presence of three copies of every chromosome rather than two, for a total of 69 chromosomes rather than the normal 46. The majority of cases are due to two sperm fertilizing a single egg. Most fetuses with triploidy are lost due to miscarriage, and the few infants born with triploidy have multiple birth defects and only survive a few months. [https://www.rarediseases.org]
Source: Regenstrief LOINC, NORD: Triploid syndrome
Observation Required in Panel
Required
Fully-Specified Name
- Component
- Fetal triploidy risk
- Property
- Imp
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Ord
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet Trip risk WBC.DNA+cfDNA Ql
- Display Name
- Triploidy risk Dosage of chromosome-specific cfDNA Ql (Plasma cell-free+WBC DNA) [Interp]
- Consumer Name Alpha Get Info
- Fetal Triploidy risk
Basic Attributes
- Class
- MOLPATH.TRISOMY
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Example Answer List LL3000-8
Answer | Code | Score | Answer ID |
---|---|---|---|
Low risk | LA19542-2 | ||
High risk | LA19541-4 | ||
Risk unchanged | LA21393-6 | ||
Test not performed Copyright http://snomed.info/sct ID:262008008 Not performed (qualifier value) | LA13546-9 |
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de triploidía fetal: |
es-ES | Spanish (Spain) | Riesgo de Triploidía: |
fr-FR | French (France) | Risque de triploïdie foetale: |
it-IT | Italian (Italy) | Triploidia, rischio: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Impressione/interpretazione di studio Patologia molecolare Plasma Punto nel tempo (episodio) Rischio triploidia Trisomia cromosoma genetica |
zh-CN | Chinese (China) | 胎儿三倍体风险: Synonyms: WBC.DNA+血浆.cfDNA; |
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
75573-6 Comment on fetal Triploidy risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Part Descriptions
LP185990-1 Comment on fetal Triploidy risk
Triploidy risk refers to the fetus's risk of being affected by triploid syndrome. The risk can be determined by prenatal genetic testing of fetal DNA. Triploid syndrome is caused by the presence of three copies of every chromosome rather than two, for a total of 69 chromosomes rather than the normal 46. The majority of cases are due to two sperm fertilizing a single egg. Most fetuses with triploidy are lost due to miscarriage, and the few infants born with triploidy have multiple birth defects and only survive a few months. [https://www.rarediseases.org]
Source: Regenstrief LOINC, NORD: Triploid syndrome
LP185990-1 Comment on fetal Triploidy risk
The genetic counselor's comment regarding risk of a specific disorder or group of disorders is used to convey follow-up recommendations or other information related to the risk result and interpretation.
Source: Regenstrief LOINC
Condition for Inclusion
If fetal triploidy risk is high, a genetic counselor comment should be included.
Observation Required in Panel
Conditional
Fully-Specified Name
- Component
- Comment on fetal Triploidy risk
- Property
- Imp
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Nar
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet Triploidy risk comment
- Display Name
- Comment on Triploidy risk Dosage of chromosome-specific cfDNA Nar (Plasma cell-free+WBC DNA) [Interp]
- Consumer Name Alpha Get Info
- Comment on fetal triploidy risk
Basic Attributes
- Class
- MOLPATH.TRISOMY
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Release 2.70: COMPONENT: Removed "Genetic counselor" to broaden use since various specialists may provide comments on test results.; Previous Releases: Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Comentario del consejero genético sobre el riesgo de triploidía fetal: |
es-ES | Spanish (Spain) | Comentario de consejo genético en riesgo de Triploidía: |
fr-FR | French (France) | Risque triploïdie foetale (commentaire du conseiller génétique): |
it-IT | Italian (Italy) | Commento su rischio Triploidia: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Impressione/interpretazione di studio Patologia molecolare Plasma Punto nel tempo (episodio) Rischio triploidia Trisomia cromosoma genetica |
zh-CN | Chinese (China) | 关于胎儿三倍体风险的遗传咨询师意见: Synonyms: WBC.DNA+血浆.cfDNA; |
75574-4 Fetal 22q11.2 deletion prior risk [Likelihood] based on general population risk
Part Descriptions
LP185907-5 based on general population risk
The risk of having or developing a specific disorder can be calculated by several different methods. One method uses known statistics for the general population as a whole to estimate a single individual's risk. For example, if 30 cases of a certain genetic condition that presents at birth are diagnosed in one year in a geographic area that has 300,000 live births per year, the individual infant's risk of having this condition is approximately 1 in 10,000 live births.
Source: Regenstrief LOINC
Condition for Inclusion
Microdeletion risk analysis requested as part of lab order.
Observation Required in Panel
Conditional
Fully-Specified Name
- Component
- 22q11.2 deletion prior risk
- Property
- Likelihood
- Time
- Pt
- System
- ^Fetus
- Scale
- Qn
- Method
- Based on general population risk
Additional Names
- Short Name
- Fet 22q11.2 del prior risk from Pop risk
- Display Name
- 22q11.2 del prior risk based on general population risk Qn (fetus)
- Consumer Name Alpha Get Info
- Fetal 22q11.2 deletion prior risk
Basic Attributes
- Class
- MOLPATH.DEL
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo previo de deleción 22q11.2: |
es-ES | Spanish (Spain) | Riesgo previo de deleción 22q11.2: Synonyms: Cuantitativo |
fr-FR | French (France) | Risque prédominant délétion 22q11.2: |
it-IT | Italian (Italy) | Delezione 22q11.2 rischio preesistente: Synonyms: Delezione genetica Patologia molecolare Punto nel tempo (episodio) |
zh-CN | Chinese (China) | 22q11.2 染色体缺失先验风险: Synonyms: 22q11.2 染色体缺失(基因缺失、 |
Example Units
Unit | Source |
---|---|
{risk} | Example UCUM Units |
75575-1 Fetal 22q11.2 deletion prior risk [Likelihood] based on general population risk Narrative
Part Descriptions
LP185907-5 based on general population risk
The risk of having or developing a specific disorder can be calculated by several different methods. One method uses known statistics for the general population as a whole to estimate a single individual's risk. For example, if 30 cases of a certain genetic condition that presents at birth are diagnosed in one year in a geographic area that has 300,000 live births per year, the individual infant's risk of having this condition is approximately 1 in 10,000 live births.
Source: Regenstrief LOINC
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- 22q11.2 deletion prior risk
- Property
- Likelihood
- Time
- Pt
- System
- ^Fetus
- Scale
- Nar
- Method
- Based on general population risk
Additional Names
- Short Name
- Fet 22q11.2 del prior risk from Pop risk
- Display Name
- 22q11.2 del prior risk based on general population risk Nar (fetus)
- Consumer Name Alpha Get Info
- Fetal 22q11.2 deletion prior risk
Basic Attributes
- Class
- MOLPATH.DEL
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo previo de deleción 22q11.2: |
es-ES | Spanish (Spain) | Riesgo previo de deleción 22q11.2: |
fr-FR | French (France) | Risque prédominant délétion 22q11.2: |
it-IT | Italian (Italy) | Delezione 22q11.2 rischio preesistente: Synonyms: Delezione genetica Patologia molecolare Punto nel tempo (episodio) |
zh-CN | Chinese (China) | 22q11.2 染色体缺失先验风险: Synonyms: 22q11.2 染色体缺失(基因缺失、 |
75576-9 Fetal 22q11.2 deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions. It represents the risk based on a priori risk combined with the Panorama test result.
Source: Regenstrief LOINC
Part Descriptions
LP185776-4 Fetal 22q11.2 deletion risk
22q11.2 deletion syndrome, also known by many other names including DiGeorge syndrome, CATCH22, and velocardiofacial syndrome, is caused by the deletion of a small piece of chromosome 22. 22q11.2 deletion syndrome is associated with variable characteristics including congenital heart disease, recurrent infection due to immune dysfunction, cleft palate and other distinct facial features, cognitive delay and autoimmune disease. The general population risk of 22q11.2 deletion is about 1 in 4,000 live births, and does not change with maternal age. Fetal risk of having 22q11.2 deletion syndrome can be derived from the general population risk as well as prenatal genetic testing of fetal DNA. [MedlinePlus Condition: 22q112-deletion-syndrome]
Source: Regenstrief LOINC, GHR: 22q11.2 deletion syndrome
Condition for Inclusion
Microdeletion risk analysis requested as part of lab order.
Observation Required in Panel
Conditional
Fully-Specified Name
- Component
- Fetal 22q11.2 deletion risk
- Property
- Likelihood
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Qn
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet 22q11.2 del risk WBC.DNA+cfDNA Qn
- Display Name
- 22q11.2 del risk Dosage of chromosome-specific cfDNA Qn (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Fetal 22q11.2 deletion risk
Basic Attributes
- Class
- MOLPATH.DEL
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de deleción fetal 22q11.2: |
es-ES | Spanish (Spain) | Riesgo de deleción 22q11.2: Synonyms: Cuantitativo |
fr-FR | French (France) | Risque délétion 22q11.2 foetale: |
it-IT | Italian (Italy) | Delezione 22q11.2 rischio: Synonyms: Delezione genetica DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) |
zh-CN | Chinese (China) | 胎儿 22q11.2 染色体缺失风险: Synonyms: WBC.DNA+血浆.cfDNA; |
Example Units
Unit | Source |
---|---|
{risk} | Example UCUM Units |
75577-7 Fetal 22q11.2 deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions. It represents the risk based on a priori risk combined with the Panorama test result.
Source: Regenstrief LOINC
Part Descriptions
LP185776-4 Fetal 22q11.2 deletion risk
22q11.2 deletion syndrome, also known by many other names including DiGeorge syndrome, CATCH22, and velocardiofacial syndrome, is caused by the deletion of a small piece of chromosome 22. 22q11.2 deletion syndrome is associated with variable characteristics including congenital heart disease, recurrent infection due to immune dysfunction, cleft palate and other distinct facial features, cognitive delay and autoimmune disease. The general population risk of 22q11.2 deletion is about 1 in 4,000 live births, and does not change with maternal age. Fetal risk of having 22q11.2 deletion syndrome can be derived from the general population risk as well as prenatal genetic testing of fetal DNA. [MedlinePlus Condition: 22q112-deletion-syndrome]
Source: Regenstrief LOINC, GHR: 22q11.2 deletion syndrome
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Fetal 22q11.2 deletion risk
- Property
- Likelihood
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Nar
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet 22q11.2 del risk WBC.DNA+cfDNA
- Display Name
- 22q11.2 del risk Dosage of chromosome-specific cfDNA Nar (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Fetal 22q11.2 deletion risk
Basic Attributes
- Class
- MOLPATH.DEL
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de deleción fetal 22q11.2: |
es-ES | Spanish (Spain) | Riesgo de deleción 22q11.2: |
fr-FR | French (France) | Risque délétion 22q11.2 foetale: |
it-IT | Italian (Italy) | Delezione 22q11.2 rischio: Synonyms: Delezione genetica DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) |
zh-CN | Chinese (China) | 胎儿 22q11.2 染色体缺失风险: Synonyms: WBC.DNA+血浆.cfDNA; |
75578-5 Fetal 22q11.2 deletion risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions.
Source: Regenstrief LOINC
Part Descriptions
LP185776-4 Fetal 22q11.2 deletion risk
22q11.2 deletion syndrome, also known by many other names including DiGeorge syndrome, CATCH22, and velocardiofacial syndrome, is caused by the deletion of a small piece of chromosome 22. 22q11.2 deletion syndrome is associated with variable characteristics including congenital heart disease, recurrent infection due to immune dysfunction, cleft palate and other distinct facial features, cognitive delay and autoimmune disease. The general population risk of 22q11.2 deletion is about 1 in 4,000 live births, and does not change with maternal age. Fetal risk of having 22q11.2 deletion syndrome can be derived from the general population risk as well as prenatal genetic testing of fetal DNA. [MedlinePlus Condition: 22q112-deletion-syndrome]
Source: Regenstrief LOINC, GHR: 22q11.2 deletion syndrome
Condition for Inclusion
Microdeletion risk analysis requested as part of lab order.
Observation Required in Panel
Conditional
Fully-Specified Name
- Component
- Fetal 22q11.2 deletion risk
- Property
- Imp
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Ord
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet 22q11.2 del risk WBC.DNA+cfDNA Ql
- Display Name
- 22q11.2 del risk Dosage of chromosome-specific cfDNA Ql (Plasma cell-free+WBC DNA) [Interp]
- Consumer Name Alpha Get Info
- Fetal 22q11.2 deletion risk
Basic Attributes
- Class
- MOLPATH.DEL
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Example Answer List LL3000-8
Answer | Code | Score | Answer ID |
---|---|---|---|
Low risk | LA19542-2 | ||
High risk | LA19541-4 | ||
Risk unchanged | LA21393-6 | ||
Test not performed Copyright http://snomed.info/sct ID:262008008 Not performed (qualifier value) | LA13546-9 |
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de deleción fetal 22q11.2: |
es-ES | Spanish (Spain) | Riesgo de deleción 22q11.2: |
fr-FR | French (France) | Risque délétion 22q11.2 foetale: |
it-IT | Italian (Italy) | Delezione 22q11.2 rischio: Synonyms: Delezione genetica DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Impressione/interpretazione di studio Patologia molecolare Plasma Punto nel tempo (episodio) |
zh-CN | Chinese (China) | 胎儿 22q11.2 染色体缺失风险: Synonyms: WBC.DNA+血浆.cfDNA; |
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
75579-3 Comment on fetal 22q11.2 deletion risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions.
Source: Regenstrief LOINC
Part Descriptions
LP185989-3 Comment on fetal 22q11.2 deletion risk
22q11.2 deletion syndrome, also known by many other names including DiGeorge syndrome, CATCH22, and velocardiofacial syndrome, is caused by the deletion of a small piece of chromosome 22. 22q11.2 deletion syndrome is associated with variable characteristics including congenital heart disease, recurrent infection due to immune dysfunction, cleft palate and other distinct facial features, cognitive delay and autoimmune disease. The general population risk of 22q11.2 deletion is about 1 in 4,000 live births, and does not change with maternal age. Fetal risk of having 22q11.2 deletion syndrome can be derived from the general population risk as well as prenatal genetic testing of fetal DNA. [MedlinePlus Condition: 22q112-deletion-syndrome]
Source: Regenstrief LOINC, GHR: 22q11.2 deletion syndrome
LP185989-3 Comment on fetal 22q11.2 deletion risk
The genetic counselor's comment regarding risk of a specific disorder or group of disorders is used to convey follow-up recommendations or other information related to the risk result and interpretation.
Source: Regenstrief LOINC
Condition for Inclusion
If fetal 22q11.2 deletion risk is high, a genetic counselor comment should be included.
Observation Required in Panel
Conditional
Fully-Specified Name
- Component
- Comment on fetal 22q11.2 deletion risk
- Property
- Txt
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Nar
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet 22q11.2 del risk comment
- Display Name
- Comment on fetal 22q11.2 del risk Dosage of chromosome-specific cfDNA Nar (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Fetal Comment on fetal 22q11.2 deletion risk
Basic Attributes
- Class
- MOLPATH.DEL
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Release 2.70: COMPONENT: Removed "Genetic counselor" to broaden use since various specialists may provide comments on test results.; Previous Releases: Added "fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Comentario del asesor genético sobre el riesgo de deleción fetal 22q11.2: |
es-ES | Spanish (Spain) | Comentario de consejo genético en riesgo de deleción 22q11,2: |
fr-FR | French (France) | Risque délétion 22q11.2 foetale (commentaire du conseiller génétique): |
it-IT | Italian (Italy) | Commento su rischio delezione 22q11.2: Synonyms: Delezione genetica DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) Testo |
zh-CN | Chinese (China) | 关于胎儿 22q11.2 染色体缺失风险的遗传咨询师意见: Synonyms: WBC.DNA+血浆.cfDNA; |
75598-3 Fetal 1p36 deletion prior risk [Likelihood] based on general population risk
Part Descriptions
LP185907-5 based on general population risk
The risk of having or developing a specific disorder can be calculated by several different methods. One method uses known statistics for the general population as a whole to estimate a single individual's risk. For example, if 30 cases of a certain genetic condition that presents at birth are diagnosed in one year in a geographic area that has 300,000 live births per year, the individual infant's risk of having this condition is approximately 1 in 10,000 live births.
Source: Regenstrief LOINC
Condition for Inclusion
Microdeletion risk analysis requested as part of lab order.
Observation Required in Panel
Conditional
Fully-Specified Name
- Component
- 1p36 deletion prior risk
- Property
- Likelihood
- Time
- Pt
- System
- ^Fetus
- Scale
- Qn
- Method
- Based on general population risk
Additional Names
- Short Name
- Fet 1p36 del prior risk from Pop risk
- Display Name
- 1p36 del prior risk based on general population risk Qn (fetus)
- Consumer Name Alpha Get Info
- Fetal 1p36 deletion prior risk
Basic Attributes
- Class
- MOLPATH.DEL
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo previo de deleción 1p36: |
es-ES | Spanish (Spain) | Riesgo previo de deleción 1p36: Synonyms: Cuantitativo |
fr-FR | French (France) | Risque prédominant délétion 1p36: |
it-IT | Italian (Italy) | Delezione 1p36 rischio preesistente: Synonyms: Delezione genetica Patologia molecolare Punto nel tempo (episodio) |
zh-CN | Chinese (China) | 1p36 染色体缺失先验风险: Synonyms: 1p36 染色体缺失(基因缺失、 |
Example Units
Unit | Source |
---|---|
{risk} | Example UCUM Units |
75599-1 Fetal 1p36 deletion prior risk [Likelihood] based on general population risk Narrative
Part Descriptions
LP185907-5 based on general population risk
The risk of having or developing a specific disorder can be calculated by several different methods. One method uses known statistics for the general population as a whole to estimate a single individual's risk. For example, if 30 cases of a certain genetic condition that presents at birth are diagnosed in one year in a geographic area that has 300,000 live births per year, the individual infant's risk of having this condition is approximately 1 in 10,000 live births.
Source: Regenstrief LOINC
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- 1p36 deletion prior risk
- Property
- Likelihood
- Time
- Pt
- System
- ^Fetus
- Scale
- Nar
- Method
- Based on general population risk
Additional Names
- Short Name
- Fet 1p36 del prior risk from Pop risk
- Display Name
- 1p36 del prior risk based on general population risk Nar (fetus)
- Consumer Name Alpha Get Info
- Fetal 1p36 deletion prior risk
Basic Attributes
- Class
- MOLPATH.DEL
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo previo de deleción 1p36: |
es-ES | Spanish (Spain) | Riesgo previo de deleción 1p36: |
fr-FR | French (France) | Risque prédominant délétion 1p36: |
it-IT | Italian (Italy) | Delezione 1p36 rischio preesistente: Synonyms: Delezione genetica Patologia molecolare Punto nel tempo (episodio) |
zh-CN | Chinese (China) | 1p36 染色体缺失先验风险: Synonyms: 1p36 染色体缺失(基因缺失、 |
75600-7 Fetal 1p36 deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions. It represents the risk based on a priori risk combined with the Panorama test result.
Source: Regenstrief LOINC
Part Descriptions
LP185774-9 Fetal 1p36 deletion risk
1p36 deletion syndrome is caused by the deletion of several genes in the short arm of chromosome 1 and is associated with severe cognitive delay, seizure disorder, weak muscle tone, swallowing difficulty, and distinctive facial features. The general population risk of 1p36 deletion is about 1 in 5,000 - 10,000 live births, and does not change with maternal age. Fetal risk of having 1p36 deletion syndrome can be derived from the general population risk as well as prenatal genetic testing of fetal DNA. [MedlinePlus Condition: 1p36-deletion-syndrome]
Source: Regenstrief LOINC, GHR: 1p36 deletion syndrome
Condition for Inclusion
Microdeletion risk analysis requested as part of lab order.
Observation Required in Panel
Conditional
Fully-Specified Name
- Component
- Fetal 1p36 deletion risk
- Property
- Likelihood
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Qn
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet 1p36 del risk WBC.DNA+cfDNA Qn
- Display Name
- 1p36 del risk Dosage of chromosome-specific cfDNA Qn (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Fetal 1p36 deletion risk
Basic Attributes
- Class
- MOLPATH.DEL
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de deleción fetal 1p36: |
es-ES | Spanish (Spain) | Riesgo de deleción 1p36: Synonyms: Cuantitativo |
fr-FR | French (France) | Risque délétion 1p36 foetale: |
it-IT | Italian (Italy) | Delezione 1p36 rischio: Synonyms: Delezione genetica DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) |
zh-CN | Chinese (China) | 胎儿 1p36 染色体缺失风险: Synonyms: WBC.DNA+血浆.cfDNA; |
Example Units
Unit | Source |
---|---|
{risk} | Example UCUM Units |
75601-5 Fetal 1p36 deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions. It represents the risk based on a priori risk combined with the Panorama test result.
Source: Regenstrief LOINC
Part Descriptions
LP185774-9 Fetal 1p36 deletion risk
1p36 deletion syndrome is caused by the deletion of several genes in the short arm of chromosome 1 and is associated with severe cognitive delay, seizure disorder, weak muscle tone, swallowing difficulty, and distinctive facial features. The general population risk of 1p36 deletion is about 1 in 5,000 - 10,000 live births, and does not change with maternal age. Fetal risk of having 1p36 deletion syndrome can be derived from the general population risk as well as prenatal genetic testing of fetal DNA. [MedlinePlus Condition: 1p36-deletion-syndrome]
Source: Regenstrief LOINC, GHR: 1p36 deletion syndrome
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Fetal 1p36 deletion risk
- Property
- Likelihood
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Nar
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet 1p36 del risk WBC.DNA+cfDNA
- Display Name
- 1p36 del risk Dosage of chromosome-specific cfDNA Nar (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Fetal 1p36 deletion risk
Basic Attributes
- Class
- MOLPATH.DEL
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de deleción fetal 1p36: |
es-ES | Spanish (Spain) | Riesgo de deleción 1p36: |
fr-FR | French (France) | Risque délétion 1p36 foetale: |
it-IT | Italian (Italy) | Delezione 1p36 rischio: Synonyms: Delezione genetica DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) |
zh-CN | Chinese (China) | 胎儿 1p36 染色体缺失风险: Synonyms: WBC.DNA+血浆.cfDNA; |
75602-3 Fetal 1p36 deletion risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions.
Source: Regenstrief LOINC
Part Descriptions
LP185774-9 Fetal 1p36 deletion risk
1p36 deletion syndrome is caused by the deletion of several genes in the short arm of chromosome 1 and is associated with severe cognitive delay, seizure disorder, weak muscle tone, swallowing difficulty, and distinctive facial features. The general population risk of 1p36 deletion is about 1 in 5,000 - 10,000 live births, and does not change with maternal age. Fetal risk of having 1p36 deletion syndrome can be derived from the general population risk as well as prenatal genetic testing of fetal DNA. [MedlinePlus Condition: 1p36-deletion-syndrome]
Source: Regenstrief LOINC, GHR: 1p36 deletion syndrome
Condition for Inclusion
Microdeletion risk analysis requested as part of lab order.
Observation Required in Panel
Conditional
Fully-Specified Name
- Component
- Fetal 1p36 deletion risk
- Property
- Imp
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Ord
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet 1p36 del risk WBC.DNA+cfDNA Ql
- Display Name
- 1p36 del risk Dosage of chromosome-specific cfDNA Ql (Plasma cell-free+WBC DNA) [Interp]
- Consumer Name Alpha Get Info
- Fetal 1p36 deletion risk
Basic Attributes
- Class
- MOLPATH.DEL
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Example Answer List LL3000-8
Answer | Code | Score | Answer ID |
---|---|---|---|
Low risk | LA19542-2 | ||
High risk | LA19541-4 | ||
Risk unchanged | LA21393-6 | ||
Test not performed Copyright http://snomed.info/sct ID:262008008 Not performed (qualifier value) | LA13546-9 |
Member of these Panels
LOINC | Long Common Name |
---|---|
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de deleción fetal 1p36: |
es-ES | Spanish (Spain) | Riesgo de deleción 1p36: |
fr-FR | French (France) | Risque délétion 1p36 foetale: |
it-IT | Italian (Italy) | Delezione 1p36 rischio: Synonyms: Delezione genetica DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Impressione/interpretazione di studio Patologia molecolare Plasma Punto nel tempo (episodio) |
zh-CN | Chinese (China) | 胎儿 1p36 染色体缺失风险: Synonyms: WBC.DNA+血浆.cfDNA; |
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
75603-1 Comment on fetal 1p36 deletion risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions.
Source: Regenstrief LOINC
Part Descriptions
LP185994-3 Comment on fetal 1p36 deletion risk
1p36 deletion syndrome is caused by the deletion of several genes in the short arm of chromosome 1 and is associated with severe cognitive delay, seizure disorder, weak muscle tone, swallowing difficulty, and distinctive facial features. The general population risk of 1p36 deletion is about 1 in 5,000 - 10,000 live births, and does not change with maternal age. Fetal risk of having 1p36 deletion syndrome can be derived from the general population risk as well as prenatal genetic testing of fetal DNA. [MedlinePlus Condition: 1p36-deletion-syndrome]
Source: Regenstrief LOINC, GHR: 1p36 deletion syndrome
LP185994-3 Comment on fetal 1p36 deletion risk
The genetic counselor's comment regarding risk of a specific disorder or group of disorders is used to convey follow-up recommendations or other information related to the risk result and interpretation.
Source: Regenstrief LOINC
Condition for Inclusion
If fetal 1p36 deletion risk is high, a genetic counselor comment should be included.
Observation Required in Panel
Conditional
Fully-Specified Name
- Component
- Comment on fetal 1p36 deletion risk
- Property
- Txt
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Nar
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet 1p36 del risk comment
- Display Name
- Comment on fetal 1p36 del risk Dosage of chromosome-specific cfDNA Nar (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Comment on fetal 1p36 deletion risk
Basic Attributes
- Class
- MOLPATH.DEL
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Release 2.70: COMPONENT: Removed "Genetic counselor" to broaden use since various specialists may provide comments on test results.; Previous Releases: Added "fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Comentario de consejo genético en riesgo general de deleción 1p36: |
es-MX | Spanish (Mexico) | Comentario del asesor genético sobre el riesgo de deleción fetal 1p36: |
fr-FR | French (France) | Risque délétion 1p36 foetale (commentaire du conseiller génétique): |
it-IT | Italian (Italy) | Commento su rischio delezione 1p36: Synonyms: Delezione genetica DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) Testo |
zh-CN | Chinese (China) | 关于胎儿 1p36 染色体缺失风险的遗传咨询师意见: Synonyms: WBC.DNA+血浆.cfDNA; |
75586-8 Fetal Angelman syndrome prior risk [Likelihood] based on general population risk
Part Descriptions
LP185907-5 based on general population risk
The risk of having or developing a specific disorder can be calculated by several different methods. One method uses known statistics for the general population as a whole to estimate a single individual's risk. For example, if 30 cases of a certain genetic condition that presents at birth are diagnosed in one year in a geographic area that has 300,000 live births per year, the individual infant's risk of having this condition is approximately 1 in 10,000 live births.
Source: Regenstrief LOINC
Condition for Inclusion
Microdeletion risk analysis requested as part of lab order.
Observation Required in Panel
Conditional
Fully-Specified Name
- Component
- Angelman syndrome prior risk
- Property
- Likelihood
- Time
- Pt
- System
- ^Fetus
- Scale
- Qn
- Method
- Based on general population risk
Additional Names
- Short Name
- Fet AS prior risk from Pop risk
- Display Name
- Angelman syndrome prior risk based on general population risk Qn (fetus)
- Consumer Name Alpha Get Info
- Fetal Angelman syndrome prior risk
Basic Attributes
- Class
- MOLPATH
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo previo del síndrome de Angelman: |
es-ES | Spanish (Spain) | Riesgo previo de síndrome de Angelman: Synonyms: Cuantitativo |
fr-FR | French (France) | Risque prédominant syndrome d'Angelman: |
it-IT | Italian (Italy) | Sindrome di Angelman, rischio preesistente: Synonyms: Patologia molecolare Punto nel tempo (episodio) Rischio preesistente di sindrome di Angelman |
zh-CN | Chinese (China) | 安吉尔曼综合征先验风险: Synonyms: 分子病理学; |
Example Units
Unit | Source |
---|---|
{risk} | Example UCUM Units |
75587-6 Fetal Angelman syndrome prior risk [Likelihood] based on general population risk Narrative
Part Descriptions
LP185907-5 based on general population risk
The risk of having or developing a specific disorder can be calculated by several different methods. One method uses known statistics for the general population as a whole to estimate a single individual's risk. For example, if 30 cases of a certain genetic condition that presents at birth are diagnosed in one year in a geographic area that has 300,000 live births per year, the individual infant's risk of having this condition is approximately 1 in 10,000 live births.
Source: Regenstrief LOINC
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Angelman syndrome prior risk
- Property
- Likelihood
- Time
- Pt
- System
- ^Fetus
- Scale
- Nar
- Method
- Based on general population risk
Additional Names
- Short Name
- Fet AS prior risk from Pop risk
- Display Name
- Angelman syndrome prior risk based on general population risk Nar (fetus)
- Consumer Name Alpha Get Info
- Fetal Angelman syndrome prior risk
Basic Attributes
- Class
- MOLPATH
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo previo del síndrome de Angelman: |
es-ES | Spanish (Spain) | Riesgo previo de síndrome de Angelman: |
fr-FR | French (France) | Risque prédominant syndrome d'Angelman: |
it-IT | Italian (Italy) | Sindrome di Angelman, rischio preesistente: Synonyms: Patologia molecolare Punto nel tempo (episodio) Rischio preesistente di sindrome di Angelman |
zh-CN | Chinese (China) | 安吉尔曼综合征先验风险: Synonyms: 分子病理学; |
75588-4 Fetal Angelman syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions. It represents the risk based on a priori risk combined with the Panorama test result.
Source: Regenstrief LOINC
Part Descriptions
LP185771-5 Fetal Angelman syndrome risk
Angelman syndrome risk refers to the fetus's risk of having Angelman syndrome. The risk for the fetus can be derived from the general population risk as well as prenatal genetic testing of fetal DNA.Angelman syndrome is primarily caused by the functional loss of the UBE3A gene on chromosome 15. In certain areas of the brain, only the maternal copy of this gene is active due to genomic imprinting, and in Angelman syndrome, the maternal copy is missing. The genetic basis for Angelman syndrome is the inverse of the basis for Prader-Willi syndrome, in which the paternal copy of certain genes on chromosome 15 are missing. About 70% of cases are due to the deletion of a portion of the maternal chromosome 15, and another 11% are due to a mutation in the maternal copy of UBE3A. Cases may also be due to the presence of two paternal chromosome 15 copies (called uniparental disomy, meaning two copies from one parent) instead of one maternal and one paternal, chromosomal translocation, or abnormal inactivation of genes on maternal chromosome 15. In 10 to 15% of cases, the cause is unknown.
Angelman syndrome is associated with cognitive delay, seizure disorder, speech impairment, and microcephaly. Children with Angelman syndrome exhibit a happy appearance with frequent smiling, laughing, and hand-flapping, as well as hyperactivity and short attention span. The general population risk of Angelman syndrome is about 1 in 12,000 - 20,000 live births, and does not change with maternal age. [MedlinePlus Condition: angelman-syndrome]
Source: Regenstrief LOINC, GHR: Angelman syndrome
Condition for Inclusion
Microdeletion risk analysis requested as part of lab order.
Observation Required in Panel
Conditional
Fully-Specified Name
- Component
- Fetal Angelman syndrome risk
- Property
- Likelihood
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Qn
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet AS risk WBC.DNA+cfDNA Qn
- Display Name
- Angelman syndrome risk Dosage of chromosome-specific cfDNA Qn (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Fetal Angelman syndrome risk
Basic Attributes
- Class
- MOLPATH
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de síndrome de Angelman fetal: |
es-ES | Spanish (Spain) | Riesgo de síndrome de Angelman: Synonyms: Cuantitativo |
fr-FR | French (France) | Risque syndrome d'Angelman foetal: |
it-IT | Italian (Italy) | Sindrome di Angelman, rischio: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di sindrome di Angelman |
zh-CN | Chinese (China) | 胎儿安吉尔曼综合征风险: Synonyms: WBC.DNA+血浆.cfDNA; |
Example Units
Unit | Source |
---|---|
{risk} | Example UCUM Units |
75589-2 Fetal Angelman syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions. It represents the risk based on a priori risk combined with the Panorama test result.
Source: Regenstrief LOINC
Part Descriptions
LP185771-5 Fetal Angelman syndrome risk
Angelman syndrome risk refers to the fetus's risk of having Angelman syndrome. The risk for the fetus can be derived from the general population risk as well as prenatal genetic testing of fetal DNA.Angelman syndrome is primarily caused by the functional loss of the UBE3A gene on chromosome 15. In certain areas of the brain, only the maternal copy of this gene is active due to genomic imprinting, and in Angelman syndrome, the maternal copy is missing. The genetic basis for Angelman syndrome is the inverse of the basis for Prader-Willi syndrome, in which the paternal copy of certain genes on chromosome 15 are missing. About 70% of cases are due to the deletion of a portion of the maternal chromosome 15, and another 11% are due to a mutation in the maternal copy of UBE3A. Cases may also be due to the presence of two paternal chromosome 15 copies (called uniparental disomy, meaning two copies from one parent) instead of one maternal and one paternal, chromosomal translocation, or abnormal inactivation of genes on maternal chromosome 15. In 10 to 15% of cases, the cause is unknown.
Angelman syndrome is associated with cognitive delay, seizure disorder, speech impairment, and microcephaly. Children with Angelman syndrome exhibit a happy appearance with frequent smiling, laughing, and hand-flapping, as well as hyperactivity and short attention span. The general population risk of Angelman syndrome is about 1 in 12,000 - 20,000 live births, and does not change with maternal age. [MedlinePlus Condition: angelman-syndrome]
Source: Regenstrief LOINC, GHR: Angelman syndrome
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Fetal Angelman syndrome risk
- Property
- Likelihood
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Nar
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet AS risk WBC.DNA+cfDNA
- Display Name
- Angelman syndrome risk Dosage of chromosome-specific cfDNA Nar (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Fetal Angelman syndrome risk
Basic Attributes
- Class
- MOLPATH
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de síndrome de Angelman fetal: |
es-ES | Spanish (Spain) | Riesgo de síndrome de Angelman: |
fr-FR | French (France) | Risque syndrome d'Angelman foetal: |
it-IT | Italian (Italy) | Sindrome di Angelman, rischio: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di sindrome di Angelman |
zh-CN | Chinese (China) | 胎儿安吉尔曼综合征风险: Synonyms: WBC.DNA+血浆.cfDNA; |
75590-0 Fetal Angelman syndrome risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions.
Source: Regenstrief LOINC
Part Descriptions
LP185771-5 Fetal Angelman syndrome risk
Angelman syndrome risk refers to the fetus's risk of having Angelman syndrome. The risk for the fetus can be derived from the general population risk as well as prenatal genetic testing of fetal DNA.Angelman syndrome is primarily caused by the functional loss of the UBE3A gene on chromosome 15. In certain areas of the brain, only the maternal copy of this gene is active due to genomic imprinting, and in Angelman syndrome, the maternal copy is missing. The genetic basis for Angelman syndrome is the inverse of the basis for Prader-Willi syndrome, in which the paternal copy of certain genes on chromosome 15 are missing. About 70% of cases are due to the deletion of a portion of the maternal chromosome 15, and another 11% are due to a mutation in the maternal copy of UBE3A. Cases may also be due to the presence of two paternal chromosome 15 copies (called uniparental disomy, meaning two copies from one parent) instead of one maternal and one paternal, chromosomal translocation, or abnormal inactivation of genes on maternal chromosome 15. In 10 to 15% of cases, the cause is unknown.
Angelman syndrome is associated with cognitive delay, seizure disorder, speech impairment, and microcephaly. Children with Angelman syndrome exhibit a happy appearance with frequent smiling, laughing, and hand-flapping, as well as hyperactivity and short attention span. The general population risk of Angelman syndrome is about 1 in 12,000 - 20,000 live births, and does not change with maternal age. [MedlinePlus Condition: angelman-syndrome]
Source: Regenstrief LOINC, GHR: Angelman syndrome
Condition for Inclusion
Microdeletion risk analysis requested as part of lab order.
Observation Required in Panel
Conditional
Fully-Specified Name
- Component
- Fetal Angelman syndrome risk
- Property
- Imp
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Ord
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet AS risk WBC.DNA+cfDNA Ql
- Display Name
- Angelman syndrome risk Dosage of chromosome-specific cfDNA Ql (Plasma cell-free+WBC DNA) [Interp]
- Consumer Name Alpha Get Info
- Fetal Angelman syndrome risk
Basic Attributes
- Class
- MOLPATH
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Example Answer List LL3000-8
Answer | Code | Score | Answer ID |
---|---|---|---|
Low risk | LA19542-2 | ||
High risk | LA19541-4 | ||
Risk unchanged | LA21393-6 | ||
Test not performed Copyright http://snomed.info/sct ID:262008008 Not performed (qualifier value) | LA13546-9 |
Member of these Panels
LOINC | Long Common Name |
---|---|
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de síndrome de Angelman fetal: |
es-ES | Spanish (Spain) | Riesgo de síndrome de Angelman: |
fr-FR | French (France) | Risque syndrome d'Angelman foetal: |
it-IT | Italian (Italy) | Sindrome di Angelman, rischio: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Impressione/interpretazione di studio Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di sindrome di Angelman |
zh-CN | Chinese (China) | 胎儿安吉尔曼综合征风险: Synonyms: WBC.DNA+血浆.cfDNA; |
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
75591-8 Comment on fetal Angelman syndrome risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions.
Source: Regenstrief LOINC
Part Descriptions
LP185991-9 Comment on fetal Angelman syndrome risk
Angelman syndrome risk refers to the fetus's risk of having Angelman syndrome. The risk for the fetus can be derived from the general population risk as well as prenatal genetic testing of fetal DNA.Angelman syndrome is primarily caused by the functional loss of the UBE3A gene on chromosome 15. In certain areas of the brain, only the maternal copy of this gene is active due to genomic imprinting, and in Angelman syndrome, the maternal copy is missing. The genetic basis for Angelman syndrome is the inverse of the basis for Prader-Willi syndrome, in which the paternal copy of certain genes on chromosome 15 are missing. About 70% of cases are due to the deletion of a portion of the maternal chromosome 15, and another 11% are due to a mutation in the maternal copy of UBE3A. Cases may also be due to the presence of two paternal chromosome 15 copies (called uniparental disomy, meaning two copies from one parent) instead of one maternal and one paternal, chromosomal translocation, or abnormal inactivation of genes on maternal chromosome 15. In 10 to 15% of cases, the cause is unknown.
Angelman syndrome is associated with cognitive delay, seizure disorder, speech impairment, and microcephaly. Children with Angelman syndrome exhibit a happy appearance with frequent smiling, laughing, and hand-flapping, as well as hyperactivity and short attention span. The general population risk of Angelman syndrome is about 1 in 12,000 - 20,000 live births, and does not change with maternal age. [MedlinePlus Condition: angelman-syndrome]
Source: Regenstrief LOINC, GHR: Angelman syndrome
LP185991-9 Comment on fetal Angelman syndrome risk
The genetic counselor's comment regarding risk of a specific disorder or group of disorders is used to convey follow-up recommendations or other information related to the risk result and interpretation.
Source: Regenstrief LOINC
Condition for Inclusion
If fetal Angelman syndrome risk is high, a genetic counselor comment should be included.
Observation Required in Panel
Conditional
Fully-Specified Name
- Component
- Comment on fetal Angelman syndrome risk
- Property
- Txt
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Nar
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet AS risk comment
- Display Name
- Comment on Angelman syndrome risk Dosage of chromosome-specific cfDNA Nar (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Comment on Angelman syndrome risk
Basic Attributes
- Class
- MOLPATH
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Release 2.70: COMPONENT: Removed "Genetic counselor" to broaden use since various specialists may provide comments on test results.; Previous Releases: Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Comentario del consejero genético sobre el riesgo de síndrome de Angelman fetal: |
es-ES | Spanish (Spain) | Comentario de consejo genético en riesgo de síndrome de Angelman: |
fr-FR | French (France) | Risque syndrome d'Angelman foetal (commentaire du conseiller génétique): |
it-IT | Italian (Italy) | Commento su rischio sindrome di Angelman: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di sindrome di Angelman Testo |
zh-CN | Chinese (China) | 关于胎儿安吉尔曼综合征风险的遗传咨询师意见: Synonyms: WBC.DNA+血浆.cfDNA; |
75592-6 Fetal 5p deletion prior risk [Likelihood] based on general population risk
Part Descriptions
LP185907-5 based on general population risk
The risk of having or developing a specific disorder can be calculated by several different methods. One method uses known statistics for the general population as a whole to estimate a single individual's risk. For example, if 30 cases of a certain genetic condition that presents at birth are diagnosed in one year in a geographic area that has 300,000 live births per year, the individual infant's risk of having this condition is approximately 1 in 10,000 live births.
Source: Regenstrief LOINC
Condition for Inclusion
Microdeletion risk analysis requested as part of lab order.
Observation Required in Panel
Conditional
Fully-Specified Name
- Component
- 5p deletion prior risk
- Property
- Likelihood
- Time
- Pt
- System
- ^Fetus
- Scale
- Qn
- Method
- Based on general population risk
Additional Names
- Short Name
- Fet 5p del prior risk from Pop risk
- Display Name
- 5p del prior risk based on general population risk Qn (fetus)
- Consumer Name Alpha Get Info
- Fetal 5p deletion prior risk
Basic Attributes
- Class
- MOLPATH.DEL
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo previo de eliminación 5p: |
es-ES | Spanish (Spain) | Riesgo previo de deleción 5p: Synonyms: Cuantitativo |
fr-FR | French (France) | Risque prédominant délétion 5p: |
it-IT | Italian (Italy) | Delezione 5p rischio preesistente: Synonyms: Delezione genetica Patologia molecolare Punto nel tempo (episodio) |
zh-CN | Chinese (China) | 5p 染色体缺失先验风险: Synonyms: 5p 染色体缺失(基因缺失、 |
Example Units
Unit | Source |
---|---|
{risk} | Example UCUM Units |
75593-4 Fetal 5p deletion prior risk [Likelihood] based on general population risk Narrative
Part Descriptions
LP185907-5 based on general population risk
The risk of having or developing a specific disorder can be calculated by several different methods. One method uses known statistics for the general population as a whole to estimate a single individual's risk. For example, if 30 cases of a certain genetic condition that presents at birth are diagnosed in one year in a geographic area that has 300,000 live births per year, the individual infant's risk of having this condition is approximately 1 in 10,000 live births.
Source: Regenstrief LOINC
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- 5p deletion prior risk
- Property
- Likelihood
- Time
- Pt
- System
- ^Fetus
- Scale
- Nar
- Method
- Based on general population risk
Additional Names
- Short Name
- Fet 5p del prior risk from Pop risk
- Display Name
- 5p del prior risk based on general population risk Nar (fetus)
- Consumer Name Alpha Get Info
- Fetal 5p deletion prior risk
Basic Attributes
- Class
- MOLPATH.DEL
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo previo de eliminación 5p: |
es-ES | Spanish (Spain) | Riesgo previo de deleción 5p: |
fr-FR | French (France) | Risque prédominant délétion 5p: |
it-IT | Italian (Italy) | Delezione 5p rischio preesistente: Synonyms: Delezione genetica Patologia molecolare Punto nel tempo (episodio) |
zh-CN | Chinese (China) | 5p 染色体缺失先验风险: Synonyms: 5p 染色体缺失(基因缺失、 |
75594-2 Fetal 5p deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions. It represents the risk based on a priori risk combined with the Panorama test result.
Source: Regenstrief LOINC
Part Descriptions
LP185908-3 Fetal 5p deletion risk
5p deletion risk refers to the fetus's risk of having 5p deletion syndrome, also known as Cri-du-chat syndrome. The risk can be derived from the general population risk as well as prenatal genetic testing of fetal DNA. 5p deletion syndrome is caused by the deletion of the short arm of chromosome 5. 5p deletion syndrome is associated with low birth weight, weak muscle tone, cognitive delay and microcephaly. The general population risk of 5p deletion is about 1 in 20,000 - 50,000 live births, and does not change with maternal age. [MedlinePlus Condition: cri-du-chat-syndrome]
Source: Regenstrief LOINC, GHR: Cri-du-chat syndrome
Condition for Inclusion
Microdeletion risk analysis requested as part of lab order.
Observation Required in Panel
Conditional
Fully-Specified Name
- Component
- Fetal 5p deletion risk
- Property
- Likelihood
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Qn
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet 5p del risk WBC.DNA+cfDNA Qn
- Display Name
- 5p del risk Dosage of chromosome-specific cfDNA Qn (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Fetal 5p deletion risk
Basic Attributes
- Class
- MOLPATH.DEL
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de deleción fetal 5p: |
es-ES | Spanish (Spain) | Riesgo de deleción 5p: Synonyms: Cuantitativo |
fr-FR | French (France) | Risque délétion 5p foetale: |
it-IT | Italian (Italy) | Delezione 5p rischio: Synonyms: Delezione genetica DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) |
zh-CN | Chinese (China) | 胎儿 5p 染色体缺失风险: Synonyms: WBC.DNA+血浆.cfDNA; |
Example Units
Unit | Source |
---|---|
{risk} | Example UCUM Units |
75595-9 Fetal 5p deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions. It represents the risk based on a priori risk combined with the Panorama test result.
Source: Regenstrief LOINC
Part Descriptions
LP185908-3 Fetal 5p deletion risk
5p deletion risk refers to the fetus's risk of having 5p deletion syndrome, also known as Cri-du-chat syndrome. The risk can be derived from the general population risk as well as prenatal genetic testing of fetal DNA. 5p deletion syndrome is caused by the deletion of the short arm of chromosome 5. 5p deletion syndrome is associated with low birth weight, weak muscle tone, cognitive delay and microcephaly. The general population risk of 5p deletion is about 1 in 20,000 - 50,000 live births, and does not change with maternal age. [MedlinePlus Condition: cri-du-chat-syndrome]
Source: Regenstrief LOINC, GHR: Cri-du-chat syndrome
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Fetal 5p deletion risk
- Property
- Likelihood
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Nar
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet 5p del risk WBC.DNA+cfDNA
- Display Name
- 5p del risk Dosage of chromosome-specific cfDNA Nar (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Fetal 5p deletion risk
Basic Attributes
- Class
- MOLPATH.DEL
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de deleción fetal 5p: |
es-ES | Spanish (Spain) | Riesgo de deleción 5p: |
fr-FR | French (France) | Risque délétion 5p foetale: |
it-IT | Italian (Italy) | Delezione 5p rischio: Synonyms: Delezione genetica DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) |
zh-CN | Chinese (China) | 胎儿 5p 染色体缺失风险: Synonyms: WBC.DNA+血浆.cfDNA; |
75596-7 Fetal 5p deletion risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions.
Source: Regenstrief LOINC
Part Descriptions
LP185908-3 Fetal 5p deletion risk
5p deletion risk refers to the fetus's risk of having 5p deletion syndrome, also known as Cri-du-chat syndrome. The risk can be derived from the general population risk as well as prenatal genetic testing of fetal DNA. 5p deletion syndrome is caused by the deletion of the short arm of chromosome 5. 5p deletion syndrome is associated with low birth weight, weak muscle tone, cognitive delay and microcephaly. The general population risk of 5p deletion is about 1 in 20,000 - 50,000 live births, and does not change with maternal age. [MedlinePlus Condition: cri-du-chat-syndrome]
Source: Regenstrief LOINC, GHR: Cri-du-chat syndrome
Condition for Inclusion
Microdeletion risk analysis requested as part of lab order.
Observation Required in Panel
Conditional
Fully-Specified Name
- Component
- Fetal 5p deletion risk
- Property
- Imp
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Ord
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet 5p del risk WBC.DNA+cfDNA Ql
- Display Name
- 5p del risk Dosage of chromosome-specific cfDNA Ql (Plasma cell-free+WBC DNA) [Interp]
- Consumer Name Alpha Get Info
- Fetal 5p deletion risk
Basic Attributes
- Class
- MOLPATH.DEL
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Example Answer List LL3000-8
Answer | Code | Score | Answer ID |
---|---|---|---|
Low risk | LA19542-2 | ||
High risk | LA19541-4 | ||
Risk unchanged | LA21393-6 | ||
Test not performed Copyright http://snomed.info/sct ID:262008008 Not performed (qualifier value) | LA13546-9 |
Member of these Panels
LOINC | Long Common Name |
---|---|
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de deleción fetal 5p: |
es-ES | Spanish (Spain) | Riesgo de deleción 5p: |
fr-FR | French (France) | Risque délétion 5p foetale: |
it-IT | Italian (Italy) | Delezione 5p rischio: Synonyms: Delezione genetica DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Impressione/interpretazione di studio Patologia molecolare Plasma Punto nel tempo (episodio) |
zh-CN | Chinese (China) | 胎儿 5p 染色体缺失风险: Synonyms: WBC.DNA+血浆.cfDNA; |
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
75597-5 Comment on fetal 5p deletion risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions.
Source: Regenstrief LOINC
Part Descriptions
LP185993-5 Comment on fetal 5p deletion risk
5p deletion risk refers to the fetus's risk of having 5p deletion syndrome, also known as Cri-du-chat syndrome. The risk can be derived from the general population risk as well as prenatal genetic testing of fetal DNA. 5p deletion syndrome is caused by the deletion of the short arm of chromosome 5. 5p deletion syndrome is associated with low birth weight, weak muscle tone, cognitive delay and microcephaly. The general population risk of 5p deletion is about 1 in 20,000 - 50,000 live births, and does not change with maternal age. [MedlinePlus Condition: cri-du-chat-syndrome]
Source: Regenstrief LOINC, GHR: Cri-du-chat syndrome
LP185993-5 Comment on fetal 5p deletion risk
The genetic counselor's comment regarding risk of a specific disorder or group of disorders is used to convey follow-up recommendations or other information related to the risk result and interpretation.
Source: Regenstrief LOINC
Condition for Inclusion
If fetal 5p deletion risk is high, a genetic counselor comment should be included.
Observation Required in Panel
Conditional
Fully-Specified Name
- Component
- Comment on fetal 5p deletion risk
- Property
- Txt
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Nar
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet 5p del risk comment
- Display Name
- Comment on fetal 5p del risk Dosage of chromosome-specific cfDNA Nar (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Fetal Comment on fetal 5p deletion risk
Basic Attributes
- Class
- MOLPATH.DEL
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Release 2.70: COMPONENT: Removed "Genetic counselor" to broaden use since various specialists may provide comments on test results.; Previous Releases: Added "fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Comentario del consejero genético sobre el riesgo de deleción fetal 5p: |
es-ES | Spanish (Spain) | Comentario de consejo genético en riesgo de deleción 5p: |
fr-FR | French (France) | Risque délétion 5p foetale (commentaire du conseiller génétique): |
it-IT | Italian (Italy) | Commento su rischio delezione 5p: Synonyms: Delezione genetica DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) Testo |
zh-CN | Chinese (China) | 关于胎儿 5p 染色体缺失风险的遗传咨询师意见: Synonyms: WBC.DNA+血浆.cfDNA; |
75580-1 Fetal Prader-Willi syndrome prior risk [Likelihood] based on general population risk
Part Descriptions
LP185907-5 based on general population risk
The risk of having or developing a specific disorder can be calculated by several different methods. One method uses known statistics for the general population as a whole to estimate a single individual's risk. For example, if 30 cases of a certain genetic condition that presents at birth are diagnosed in one year in a geographic area that has 300,000 live births per year, the individual infant's risk of having this condition is approximately 1 in 10,000 live births.
Source: Regenstrief LOINC
Condition for Inclusion
Microdeletion risk analysis requested as part of lab order.
Observation Required in Panel
Conditional
Fully-Specified Name
- Component
- Prader-Willi syndrome prior risk
- Property
- Likelihood
- Time
- Pt
- System
- ^Fetus
- Scale
- Qn
- Method
- Based on general population risk
Additional Names
- Short Name
- Fet PWS prior risk from Pop risk
- Display Name
- Prader-Willi syndrome prior risk based on general population risk Qn (fetus)
- Consumer Name Alpha Get Info
- Fetal Prader-Willi syndrome prior risk
Basic Attributes
- Class
- MOLPATH.DEL
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo previo del síndrome de Prader-Willi: |
es-ES | Spanish (Spain) | Riesgo previo de síndrome de Prader-Willi: Synonyms: Cuantitativo |
fr-FR | French (France) | Risque prédominant syndrome de Prader-Willi: |
it-IT | Italian (Italy) | Sindrome di Prader Willi, rischio preesistente: Synonyms: Delezione genetica Patologia molecolare Punto nel tempo (episodio) Rischio preesistente di sindrome di Prader Willi |
zh-CN | Chinese (China) | 普拉德-威利综合征先验风险: Synonyms: 分子病理学.基因缺失; |
Example Units
Unit | Source |
---|---|
{risk} | Example UCUM Units |
75581-9 Fetal Prader-Willi syndrome prior risk [Likelihood] based on general population risk Narrative
Part Descriptions
LP185907-5 based on general population risk
The risk of having or developing a specific disorder can be calculated by several different methods. One method uses known statistics for the general population as a whole to estimate a single individual's risk. For example, if 30 cases of a certain genetic condition that presents at birth are diagnosed in one year in a geographic area that has 300,000 live births per year, the individual infant's risk of having this condition is approximately 1 in 10,000 live births.
Source: Regenstrief LOINC
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Prader-Willi syndrome prior risk
- Property
- Likelihood
- Time
- Pt
- System
- ^Fetus
- Scale
- Nar
- Method
- Based on general population risk
Additional Names
- Short Name
- Fet PWS prior risk from Pop risk
- Display Name
- Prader-Willi syndrome prior risk based on general population risk Nar (fetus)
- Consumer Name Alpha Get Info
- Fetal Prader-Willi syndrome prior risk
Basic Attributes
- Class
- MOLPATH.DEL
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo previo del síndrome de Prader-Willi: |
es-ES | Spanish (Spain) | Riesgo previo de síndrome de Prader-Willi: |
fr-FR | French (France) | Risque prédominant syndrome de Prader-Willi: |
it-IT | Italian (Italy) | Sindrome di Prader Willi, rischio preesistente: Synonyms: Delezione genetica Patologia molecolare Punto nel tempo (episodio) Rischio preesistente di sindrome di Prader Willi |
zh-CN | Chinese (China) | 普拉德-威利综合征先验风险: Synonyms: 分子病理学.基因缺失; |
75582-7 Fetal Prader-Willi syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions. It represents the risk based on a priori risk combined with the Panorama test result.
Source: Regenstrief LOINC
Part Descriptions
LP185770-7 Fetal Prader-Willi syndrome risk
Prader-Willi syndrome (PWS) risk refers to the fetus's risk of being affected by PWS. The risk for the fetus can be derived from the general population risk as well as prenatal genetic testing of fetal DNA. PWS is caused by the functional loss of several genes on chromosome 15. Normally, only the paternal copy of these genes is active due to genomic imprinting, and in PWS, the paternal copy of these genes is missing. The genetic basis for PWS is the inverse of the basis for Angelman syndrome, in which the maternal copy of a specific gene on chromosome 15 is missing. About 70% of PWS cases are due to the deletion of a portion of the paternal chromosome 15, and another 25% are due to the presence of two maternal chromosome 15 copies (called uniparental disomy, meaning two copies from one parent) instead of one maternal and one paternal.
PWS is associated with different characteristics over time. Infants with PWS have poor growth, developmental delay, and weak muscle tone. Children with PWS develop a compulsion to eat, which leads to obesity and type 2 diabetes mellitus. PWS is associated with mild to moderate cognitive delay, behavior problems, characteristic facial features, and delayed puberty. The general population risk of PWS is about 1 in 10,000 - 30,000 live births, and does not change with maternal age. [MedlinePlus Condition: prader-willi-syndrome]
Source: Regenstrief LOINC, GHR: Prader-Willi syndrome
Condition for Inclusion
Microdeletion risk analysis requested as part of lab order.
Observation Required in Panel
Conditional
Fully-Specified Name
- Component
- Fetal Prader-Willi syndrome risk
- Property
- Likelihood
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Qn
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet PWS risk WBC.DNA+cfDNA Qn
- Display Name
- Prader-Willi syndrome risk Dosage of chromosome-specific cfDNA Qn (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Fetal Prader-Willi syndrome risk
Basic Attributes
- Class
- MOLPATH.DEL
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de síndrome de Prader-Willi fetal: |
es-ES | Spanish (Spain) | Riesgo de síndrome de Prader-Willi: Synonyms: Cuantitativo |
fr-FR | French (France) | Risque foetal du syndrome de Prader-Willi: |
it-IT | Italian (Italy) | Sindrome di Prader Willi, rischio: Synonyms: Delezione genetica DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di sindrome di Prader Willi |
zh-CN | Chinese (China) | 胎儿普拉德-威利综合征风险: Synonyms: WBC.DNA+血浆.cfDNA; |
Example Units
Unit | Source |
---|---|
{risk} | Example UCUM Units |
75583-5 Fetal Prader-Willi syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions. It represents the risk based on a priori risk combined with the Panorama test result.
Source: Regenstrief LOINC
Part Descriptions
LP185770-7 Fetal Prader-Willi syndrome risk
Prader-Willi syndrome (PWS) risk refers to the fetus's risk of being affected by PWS. The risk for the fetus can be derived from the general population risk as well as prenatal genetic testing of fetal DNA. PWS is caused by the functional loss of several genes on chromosome 15. Normally, only the paternal copy of these genes is active due to genomic imprinting, and in PWS, the paternal copy of these genes is missing. The genetic basis for PWS is the inverse of the basis for Angelman syndrome, in which the maternal copy of a specific gene on chromosome 15 is missing. About 70% of PWS cases are due to the deletion of a portion of the paternal chromosome 15, and another 25% are due to the presence of two maternal chromosome 15 copies (called uniparental disomy, meaning two copies from one parent) instead of one maternal and one paternal.
PWS is associated with different characteristics over time. Infants with PWS have poor growth, developmental delay, and weak muscle tone. Children with PWS develop a compulsion to eat, which leads to obesity and type 2 diabetes mellitus. PWS is associated with mild to moderate cognitive delay, behavior problems, characteristic facial features, and delayed puberty. The general population risk of PWS is about 1 in 10,000 - 30,000 live births, and does not change with maternal age. [MedlinePlus Condition: prader-willi-syndrome]
Source: Regenstrief LOINC, GHR: Prader-Willi syndrome
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Fetal Prader-Willi syndrome risk
- Property
- Likelihood
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Nar
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet PWS risk WBC.DNA+cfDNA
- Display Name
- Prader-Willi syndrome risk Dosage of chromosome-specific cfDNA Nar (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Fetal Prader-Willi syndrome risk
Basic Attributes
- Class
- MOLPATH.DEL
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de síndrome de Prader-Willi fetal: |
es-ES | Spanish (Spain) | Riesgo de síndrome de Prader-Willi: |
fr-FR | French (France) | Risque foetal du syndrome de Prader-Willi: |
it-IT | Italian (Italy) | Sindrome di Prader Willi, rischio: Synonyms: Delezione genetica DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di sindrome di Prader Willi |
zh-CN | Chinese (China) | 胎儿普拉德-威利综合征风险: Synonyms: WBC.DNA+血浆.cfDNA; |
75584-3 Fetal Prader-Willi syndrome risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions.
Source: Regenstrief LOINC
Part Descriptions
LP185770-7 Fetal Prader-Willi syndrome risk
Prader-Willi syndrome (PWS) risk refers to the fetus's risk of being affected by PWS. The risk for the fetus can be derived from the general population risk as well as prenatal genetic testing of fetal DNA. PWS is caused by the functional loss of several genes on chromosome 15. Normally, only the paternal copy of these genes is active due to genomic imprinting, and in PWS, the paternal copy of these genes is missing. The genetic basis for PWS is the inverse of the basis for Angelman syndrome, in which the maternal copy of a specific gene on chromosome 15 is missing. About 70% of PWS cases are due to the deletion of a portion of the paternal chromosome 15, and another 25% are due to the presence of two maternal chromosome 15 copies (called uniparental disomy, meaning two copies from one parent) instead of one maternal and one paternal.
PWS is associated with different characteristics over time. Infants with PWS have poor growth, developmental delay, and weak muscle tone. Children with PWS develop a compulsion to eat, which leads to obesity and type 2 diabetes mellitus. PWS is associated with mild to moderate cognitive delay, behavior problems, characteristic facial features, and delayed puberty. The general population risk of PWS is about 1 in 10,000 - 30,000 live births, and does not change with maternal age. [MedlinePlus Condition: prader-willi-syndrome]
Source: Regenstrief LOINC, GHR: Prader-Willi syndrome
Condition for Inclusion
Microdeletion risk analysis requested as part of lab order.
Observation Required in Panel
Conditional
Fully-Specified Name
- Component
- Fetal Prader-Willi syndrome risk
- Property
- Imp
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Ord
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet PWS risk WBC.DNA+cfDNA Ql
- Display Name
- Prader-Willi syndrome risk Dosage of chromosome-specific cfDNA Ql (Plasma cell-free+WBC DNA) [Interp]
- Consumer Name Alpha Get Info
- Fetal Prader-Willi syndrome risk
Basic Attributes
- Class
- MOLPATH.DEL
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Example Answer List LL3000-8
Answer | Code | Score | Answer ID |
---|---|---|---|
Low risk | LA19542-2 | ||
High risk | LA19541-4 | ||
Risk unchanged | LA21393-6 | ||
Test not performed Copyright http://snomed.info/sct ID:262008008 Not performed (qualifier value) | LA13546-9 |
Member of these Panels
LOINC | Long Common Name |
---|---|
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Riesgo de síndrome de Prader-Willi fetal: |
es-ES | Spanish (Spain) | Riesgo de síndrome de Prader-Willi: |
fr-FR | French (France) | Risque foetal du syndrome de Prader-Willi: |
it-IT | Italian (Italy) | Sindrome di Prader Willi, rischio: Synonyms: Delezione genetica DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Impressione/interpretazione di studio Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di sindrome di Prader Willi |
zh-CN | Chinese (China) | 胎儿普拉德-威利综合征风险: Synonyms: WBC.DNA+血浆.cfDNA; |
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
75585-0 Comment on fetal Prader-Willi syndrome risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions.
Source: Regenstrief LOINC
Part Descriptions
LP185992-7 Comment on fetal Prader-Willi syndrome risk
Prader-Willi syndrome (PWS) risk refers to the fetus's risk of being affected by PWS. The risk for the fetus can be derived from the general population risk as well as prenatal genetic testing of fetal DNA. PWS is caused by the functional loss of several genes on chromosome 15. Normally, only the paternal copy of these genes is active due to genomic imprinting, and in PWS, the paternal copy of these genes is missing. The genetic basis for PWS is the inverse of the basis for Angelman syndrome, in which the maternal copy of a specific gene on chromosome 15 is missing. About 70% of PWS cases are due to the deletion of a portion of the paternal chromosome 15, and another 25% are due to the presence of two maternal chromosome 15 copies (called uniparental disomy, meaning two copies from one parent) instead of one maternal and one paternal.
PWS is associated with different characteristics over time. Infants with PWS have poor growth, developmental delay, and weak muscle tone. Children with PWS develop a compulsion to eat, which leads to obesity and type 2 diabetes mellitus. PWS is associated with mild to moderate cognitive delay, behavior problems, characteristic facial features, and delayed puberty. The general population risk of PWS is about 1 in 10,000 - 30,000 live births, and does not change with maternal age. [MedlinePlus Condition: prader-willi-syndrome]
Source: Regenstrief LOINC, GHR: Prader-Willi syndrome
LP185992-7 Comment on fetal Prader-Willi syndrome risk
The genetic counselor's comment regarding risk of a specific disorder or group of disorders is used to convey follow-up recommendations or other information related to the risk result and interpretation.
Source: Regenstrief LOINC
Condition for Inclusion
If fetal Prader-Willi syndrome risk is high, a genetic counselor comment should be included.
Observation Required in Panel
Conditional
Fully-Specified Name
- Component
- Comment on fetal Prader-Willi syndrome risk
- Property
- Txt
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Nar
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet PWS risk comment
- Display Name
- Comment on Prader-Willi syndrome risk Dosage of chromosome-specific cfDNA Nar (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Fetal Comment on prader-Willi syndrome risk
Basic Attributes
- Class
- MOLPATH.DEL
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Release 2.70: COMPONENT: Removed "Genetic counselor" to broaden use since various specialists may provide comments on test results.; Previous Releases: Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Comentario del consejero genético sobre el riesgo de síndrome de Prader-Willi fetal: |
es-ES | Spanish (Spain) | Comentario de consejo genético en riesgo de síndrome de Prader-Willis: |
fr-FR | French (France) | Risque syndrome de Prader-Willi foetal (commentaire du conseiller génétique): |
it-IT | Italian (Italy) | Commento su rischio sindrome di Prader-Willi: Synonyms: Delezione genetica DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di sindrome di Prader Willi Testo |
zh-CN | Chinese (China) | 关于胎儿普拉德-威利综合征风险的遗传咨询师意见: Synonyms: WBC.DNA+血浆.cfDNA; |
75544-7 Noninvasive prenatal testing overall interpretation Qualitative
Term Description
The overall ordinal interpretation result for noninvasive prenatal testing (NIPT) for detection of chromosomal abnormalities or other prenatal genetic conditions.
Source: Regenstrief LOINC
Observation Required in Panel
Required
Fully-Specified Name
- Component
- Noninvasive prenatal testing overall interpretation
- Property
- Imp
- Time
- Pt
- System
- ^Fetus
- Scale
- Ord
- Method
Additional Names
- Short Name
- NIPT overall interpretation Ql
- Display Name
- Noninvasive prenatal testing overall interpretation Ql (fetus) [Interp]
- Consumer Name Alpha Get Info
- Noninvasive prenatal testing overall interpretation
Basic Attributes
- Class
- MOLPATH
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Release 2.71: COMPONENT: Broaden use-case for term to cover any noninvasive prenatal testing.; SYSTEM: Updated to represent the fetus as the subject of the result.;
- Order vs. Observation
- Observation
Example Answer List LL2353-2
Answer | Code | Score | Answer ID |
---|---|---|---|
Low risk | LA19542-2 | ||
High risk | LA19541-4 |
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Interpretación general de la aneuploidía prenatal fetal no invasiva y la microdeleción: |
es-ES | Spanish (Spain) | Interpretación general de las pruebas prenatales no invasivas: |
fr-FR | French (France) | Tests prénataux non invasifs - Interprétation globale: |
it-IT | Italian (Italy) | Test prenatale non invasivo, interpretazione generale: Synonyms: Impressione/interpretazione di studio Interpretazione generale test prenatale non invasivo Patologia molecolare Punto nel tempo (episodio) |
nl-NL | Dutch (Netherlands) | niet-invasieve prenatale test commentaar algehele interpretatie: Synonyms: NIPT |
zh-CN | Chinese (China) | 无创性产前检测总体解释: Synonyms: 依次型; |
75545-4 Noninvasive prenatal testing comment [Text]
Condition for Inclusion
If overall fetal aneuploidy and microdeletion risk is high, a genetic counselor comment should be included.
Observation Required in Panel
Conditional
Fully-Specified Name
- Component
- Noninvasive prenatal testing comment
- Property
- Txt
- Time
- Pt
- System
- ^Fetus
- Scale
- Nar
- Method
Additional Names
- Short Name
- NIPT comment
- Display Name
- Noninvasive prenatal testing comment Nar (fetus)
- Consumer Name Alpha Get Info
- Noninvasive prenatal testing comment
Basic Attributes
- Class
- MOLPATH
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Release 2.71: COMPONENT: Broaden use-case for term to cover any noninvasive prenatal testing.; Release 2.70: COMPONENT: Removed "Genetic counselor" to broaden use since various specialists may provide comments on test results.;
- Order vs. Observation
- Observation
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Comentario del asesor genético sobre el riesgo general de aneuploidía y microdeleción fetal: |
es-ES | Spanish (Spain) | Comentario del test prenatal no invasivo: |
fr-FR | French (France) | Test prénatal non invasif - Commentaire: |
it-IT | Italian (Italy) | Test prenatale non invasivo, commento: Synonyms: Commento test prenatale non invasivo Patologia molecolare Punto nel tempo (episodio) Testo |
nl-NL | Dutch (Netherlands) | niet-invasieve prenatale test commentaar: Synonyms: NIPT |
zh-CN | Chinese (China) | 无创性产前检测注释: Synonyms: 分子病理学; |
75608-0 Citation [Bibliographic Citation] in Referral lab test Narrative
Part Descriptions
LP72255-0 Citation
Citations include journal articles, textbooks, and other sources that may be cited as a source of information.
Source: Regenstrief LOINC
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Citation
- Property
- Bib
- Time
- Pt
- System
- Referral lab test
- Scale
- Nar
- Method
Additional Names
- Short Name
- Citation Ref Lab Test
- Display Name
- Citation Nar (Referral lab test)
- Consumer Name Alpha Get Info
- Referral Lab Test Citation
Basic Attributes
- Class
- MISC
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Release 2.70: SYSTEM: Updated "Reference" to "Referral" to broaden use and apply to any referral lab, not just reference labs.;
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 6520
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Citación: |
es-ES | Spanish (Spain) | Citación: |
fr-FR | French (France) | Citation: |
it-IT | Italian (Italy) | Citazione: Synonyms: Citazione bibliografica Miscellanea Punto nel tempo (episodio) Test del laboratorio di riferimento |
zh-CN | Chinese (China) | 引文: Synonyms: 书目引用; |
68989-3 Performing laboratory [Address]
Term Description
Term would be especially important to users of HL7 v2.x (where x<5.1) for carrying information that v2.5a carries in a dedicated field (OBX-24)
Source: Regenstrief LOINC
Observation Required in Panel
Required
Fully-Specified Name
- Component
- Performing laboratory
- Property
- Addr
- Time
- Pt
- System
- Facility
- Scale
- Nom
- Method
Additional Names
- Short Name
- Performing lab Addr
- Display Name
- Performing laboratory Nom (Facility)
- Consumer Name Alpha Get Info
- Performing laboratory, Facility
Basic Attributes
- Class
- MISC
- Type
- Laboratory
- First Released
- Version 2.38
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
HL7® Attributes
HL7® Field ID- OBX-24
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Realización de laboratorio: |
es-ES | Spanish (Spain) | Realización del labloratorio: |
it-IT | Italian (Italy) | Laboratorio che esegue il test: Synonyms: Indirizzo (HL7 data type) Miscellanea Punto nel tempo (episodio) |
nl-NL | Dutch (Netherlands) | uitvoerend laboratorium: |
pl-PL | Polish (Poland) | Laboratorium wykonujące: |
ru-RU | Russian (Russian Federation) | Исполняющая лаборатория: Synonyms: Адрес (HL7 data type) Лаборатория, выполняющая анализ Номинальный; |
tr-TR | Turkish (Turkey) | Uygulayan laboratuvar/Testi çalışan laboratuvar: |
zh-CN | Chinese (China) | 执行实验室: Synonyms: 分类型应答; |
75549-6 Performing laboratory phone number
Observation Required in Panel
Required
Fully-Specified Name
- Component
- Performing laboratory phone number
- Property
- Tele
- Time
- Pt
- System
- Facility
- Scale
- Nom
- Method
Additional Names
- Short Name
- Performing lab phone #
- Display Name
- Performing laboratory phone Nom (Facility)
Basic Attributes
- Class
- ADMIN.FACILITY
- Type
- Clinical
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Realizar el número de teléfono del laboratorio: |
es-ES | Spanish (Spain) | Teléfono del laboratorio: Synonyms: Número de teléfono (datos de HL7) |
it-IT | Italian (Italy) | Laboratorio che esegue il test, recapito telefonico: Synonyms: Amministrativo Numero di telefono (HL7 datatype) Punto nel tempo (episodio) Recapito telefonico del laboratorio che esegue il test Struttura |
tr-TR | Turkish (Turkey) | Uygulayan laboratuvar telefonu: |
zh-CN | Chinese (China) | 执行方实验室电话号码: Synonyms: 个数; |